10.07.2015 Views

Guidelines for Monitoring and Management of Pediatric Patients ...

Guidelines for Monitoring and Management of Pediatric Patients ...

Guidelines for Monitoring and Management of Pediatric Patients ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Guidelines</strong> <strong>for</strong> <strong>Monitoring</strong> <strong>and</strong> <strong>Management</strong> <strong>of</strong> <strong>Pediatric</strong> <strong>Patients</strong> During <strong>and</strong>After Sedation <strong>for</strong> Diagnostic <strong>and</strong> Therapeutic Procedures: An UpdateAmerican Academy <strong>of</strong> <strong>Pediatric</strong>s, American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry, CharlesJ. Coté <strong>and</strong> Stephen Wilson<strong>Pediatric</strong>s 2006;118;2587DOI: 10.1542/peds.2006-2780The online version <strong>of</strong> this article, along with updated in<strong>for</strong>mation <strong>and</strong> services, islocated on the World Wide Web at:http://pediatrics.aappublications.org/content/118/6/2587.full.htmlPEDIATRICS is the <strong>of</strong>ficial journal <strong>of</strong> the American Academy <strong>of</strong> <strong>Pediatric</strong>s. A monthlypublication, it has been published continuously since 1948. PEDIATRICS is owned,published, <strong>and</strong> trademarked by the American Academy <strong>of</strong> <strong>Pediatric</strong>s, 141 Northwest PointBoulevard, Elk Grove Village, Illinois, 60007. Copyright © 2006 by the American Academy<strong>of</strong> <strong>Pediatric</strong>s. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


CLINICAL REPORT<strong>Guidelines</strong> <strong>for</strong> <strong>Monitoring</strong> <strong>and</strong><strong>Management</strong> <strong>of</strong> <strong>Pediatric</strong> <strong>Patients</strong>During <strong>and</strong> After Sedation <strong>for</strong>Diagnostic <strong>and</strong> TherapeuticProcedures: An UpdateGuidance <strong>for</strong> the Clinician in Rendering<strong>Pediatric</strong> CareAMERICAN ACADEMY OF PEDIATRICSAMERICAN ACADEMY OF PEDIATRIC DENTISTRYCharles J. Coté, MD, Stephen Wilson, DMD, MA, PhD, the Work Group on SedationABSTRACTThe safe sedation <strong>of</strong> children <strong>for</strong> procedures requires a systematic approach thatincludes the following: no administration <strong>of</strong> sedating medication without thesafety net <strong>of</strong> medical supervision; careful presedation evaluation <strong>for</strong> underlyingmedical or surgical conditions that would place the child at increased risk fromsedating medications; appropriate fasting <strong>for</strong> elective procedures <strong>and</strong> a balancebetween depth <strong>of</strong> sedation <strong>and</strong> risk <strong>for</strong> those who are unable to fast because <strong>of</strong> theurgent nature <strong>of</strong> the procedure; a focused airway examination <strong>for</strong> large tonsils oranatomic airway abnormalities that might increase the potential <strong>for</strong> airway obstruction;a clear underst<strong>and</strong>ing <strong>of</strong> the pharmacokinetic <strong>and</strong> pharmacodynamiceffects <strong>of</strong> the medications used <strong>for</strong> sedation, as well as an appreciation <strong>for</strong> druginteractions; appropriate training <strong>and</strong> skills in airway management to allow rescue<strong>of</strong> the patient; age- <strong>and</strong> size-appropriate equipment <strong>for</strong> airway management <strong>and</strong>venous access; appropriate medications <strong>and</strong> reversal agents; sufficient numbers <strong>of</strong>people to carry out the procedure <strong>and</strong> monitor the patient; appropriate physiologicmonitoring during <strong>and</strong> after the procedure; a properly equipped <strong>and</strong> staffedrecovery area; recovery to presedation level <strong>of</strong> consciousness be<strong>for</strong>e dischargefrom medical supervision; <strong>and</strong> appropriate discharge instructions. This report wasdeveloped through a collaborative ef<strong>for</strong>t <strong>of</strong> the American Academy <strong>of</strong> <strong>Pediatric</strong>s<strong>and</strong> the American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry to <strong>of</strong>fer pediatric providersupdated in<strong>for</strong>mation <strong>and</strong> guidance in delivering safe sedation to children.INTRODUCTIONInvasive diagnostic <strong>and</strong> minor surgical procedures on pediatric patients outside thetraditional operating room setting have increased in the last decade. As a consequence<strong>of</strong> this change <strong>and</strong> the increased awareness <strong>of</strong> the importance <strong>of</strong> providinganalgesia <strong>and</strong> anxiolysis, the need <strong>for</strong> sedation <strong>for</strong> procedures in physician <strong>of</strong>fices,dental <strong>of</strong>fices, subspecialty procedure suites, imaging facilities, emergency departments,<strong>and</strong> ambulatory surgery centers has also markedly increased. 1–37 In recognition<strong>of</strong> this need <strong>for</strong> both elective <strong>and</strong> emergency use <strong>of</strong> sedation in nontraditionalsettings, the American Academy <strong>of</strong> <strong>Pediatric</strong>s (AAP) <strong>and</strong> American Academywww.pediatrics.org/cgi/doi/10.1542/peds.2006-2780doi:10.1542/peds.2006-2780All clinical reports from the AmericanAcademy <strong>of</strong> <strong>Pediatric</strong>s automaticallyexpire 5 years after publication unlessreaffirmed, revised, or retired at orbe<strong>for</strong>e that time.The guidance in this report does notindicate an exclusive course <strong>of</strong> treatmentor serve as a st<strong>and</strong>ard <strong>of</strong> medical care.Variations, taking into account individualcircumstances, may be appropriate.Key Wordssedation, guidelines, procedures, adverseevents, outcomes, accidents, prevention,monitoring, drug interactions, pediatric,childrenAbbreviationsAAP—American Academy <strong>of</strong> <strong>Pediatric</strong>sAAPD—American Academy <strong>of</strong> <strong>Pediatric</strong>DentistryASA—American Society <strong>of</strong>AnesthesiologistsEMS—emergency medical servicesECG—electrocardiographyLMA—laryngeal mask airwayPEDIATRICS (ISSN Numbers: Print, 0031-4005;Online, 1098-4275). Copyright © 2006 by theAmerican Academy <strong>of</strong> <strong>Pediatric</strong>s <strong>and</strong> theAmerican Academy <strong>of</strong> <strong>Pediatric</strong> DentistryPEDIATRICS Volume 118, Number 6, December 2006 2587Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


<strong>of</strong> <strong>Pediatric</strong> Dentistry (AAPD) have published a series <strong>of</strong>guidelines <strong>for</strong> the monitoring <strong>and</strong> management <strong>of</strong> pediatricpatients during <strong>and</strong> after sedation <strong>for</strong> a procedure.38–42 The purpose <strong>of</strong> this updated statement is tounify the guidelines <strong>for</strong> sedation used by medical <strong>and</strong>dental practitioners, add clarifications regarding monitoringmodalities, provide new in<strong>for</strong>mation from medical<strong>and</strong> dental literature, <strong>and</strong> suggest methods <strong>for</strong> furtherimprovement in safety <strong>and</strong> outcomes. With the revision<strong>of</strong> this document, the Joint Commission on Accreditation<strong>of</strong> Healthcare Organizations, the American Society<strong>of</strong> Anesthesiologists (ASA), the AAP, <strong>and</strong> the AAPD willuse similar language to define sedation categories <strong>and</strong>the expected physiologic responses. 41–44This revised statement reflects the current underst<strong>and</strong>ing<strong>of</strong> appropriate monitoring needs both during<strong>and</strong> after sedation <strong>for</strong> a procedure. 4,5,12,19,21,22,26,45–53 Themonitoring <strong>and</strong> care outlined in these guidelines may beexceeded at any time on the basis <strong>of</strong> the judgment <strong>of</strong> theresponsible practitioner. Although intended to encouragehigh-quality patient care, adherence to these guidelinescannot guarantee a specific patient outcome. However,structured sedation protocols designed toincorporate the principles in this document have beenwidely implemented <strong>and</strong> shown to reduce morbidity.29,32–34,37,54,55 These guidelines are pr<strong>of</strong>fered with theawareness that, regardless <strong>of</strong> the intended level <strong>of</strong> sedationor route <strong>of</strong> administration, the sedation <strong>of</strong> a pediatricpatient represents a continuum <strong>and</strong> may result inrespiratory depression <strong>and</strong> loss <strong>of</strong> the patient’s protectivereflexes. 43,56–59Sedation <strong>of</strong> pediatric patients has serious associatedrisks, such as hypoventilation, apnea, airway obstruction,laryngospasm, <strong>and</strong> cardiopulmonary impairment.2,6,22,45,46,54,60–69 These adverse responses during <strong>and</strong>after sedation <strong>for</strong> a diagnostic or therapeutic proceduremay be minimized, but not completely eliminated, by acareful preprocedure review <strong>of</strong> the patient’s underlyingmedical conditions <strong>and</strong> consideration <strong>of</strong> how the sedationprocess might affect or be affected by these conditions.54 Appropriate drug selection <strong>for</strong> the intended procedureas well as the presence <strong>of</strong> an individual with theskills needed to rescue a patient from an adverse responseare essential. Appropriate physiologic monitoring<strong>and</strong> continuous observation by personnel not directlyinvolved with the procedure allow <strong>for</strong> accurate <strong>and</strong> rapiddiagnosis <strong>of</strong> complications <strong>and</strong> initiation <strong>of</strong> appropriaterescue interventions. 46,51,54The sedation <strong>of</strong> children is different from the sedation<strong>of</strong> adults. Sedation in children is <strong>of</strong>ten administered tocontrol behavior to allow the safe completion <strong>of</strong> a procedure.A child’s ability to control his or her own behaviorto cooperate <strong>for</strong> a procedure depends both on his orher chronologic <strong>and</strong> developmental age. Often, childrenyounger than 6 years <strong>and</strong> those with developmentaldelay require deep levels <strong>of</strong> sedation to gain control <strong>of</strong>their behavior. 57 There<strong>for</strong>e, the need <strong>for</strong> deep sedationshould be anticipated. Children in this age group areparticularly vulnerable to the sedating medication’s effectson respiratory drive, patency <strong>of</strong> the airway, <strong>and</strong>protective reflexes. 46 Studies have shown that it is common<strong>for</strong> children to pass from the intended level <strong>of</strong>sedation to a deeper, unintended level <strong>of</strong> sedation. 56,59,70For older <strong>and</strong> cooperative children, other modalities,such as parental presence, hypnosis, distraction, topicallocal anesthetics, <strong>and</strong> guided imagery, may reduce theneed <strong>for</strong> or the needed depth <strong>of</strong> pharmacologic sedation.31,71–81The concept <strong>of</strong> rescue is essential to safe sedation.Practitioners <strong>of</strong> sedation must have the skills to rescuethe patient from a deeper level than that intended <strong>for</strong>the procedure. For example, if the intended level <strong>of</strong>sedation is “minimal,” practitioners must be able to rescuethe patient from “moderate sedation”; if the intendedlevel <strong>of</strong> sedation is “moderate,” practitionersmust have the skills to rescue the patient from “deepsedation”; <strong>and</strong> if the intended level <strong>of</strong> sedation is “deep,”practitioners must have the skills to rescue the patientfrom a state <strong>of</strong> “general anesthesia.” The ability to rescuemeans that practitioners must be able to recognizethe various levels <strong>of</strong> sedation <strong>and</strong> have the skills necessaryto provide appropriate cardiopulmonary supportif needed. Sedation <strong>and</strong> anesthesia in a nonhospital environment(private physician or dental <strong>of</strong>fice or freest<strong>and</strong>ingimaging facility) may be associated with anincreased incidence <strong>of</strong> “failure to rescue” the patientshould an adverse event occur, because the only backupin this venue may be to activate emergency medicalservices (EMS). 46,82 Rescue therapies require specifictraining <strong>and</strong> skills. 46,54,83,84 Maintenance <strong>of</strong> the skillsneeded to per<strong>for</strong>m successful bag-valve-mask ventilationis essential to successfully rescue a child who hasbecome apneic or developed airway obstruction. Familiaritywith emergency airway management procedurealgorithms is essential. 83–87 Practitioners should have anin-depth knowledge <strong>of</strong> the agents they intend to use <strong>and</strong>their potential complications. A number <strong>of</strong> reviews <strong>and</strong>h<strong>and</strong>books <strong>for</strong> sedating pediatric patients are available.32,48,55,88–93 These guidelines are intended <strong>for</strong> all venuesin which sedation <strong>for</strong> a procedure might be per<strong>for</strong>med(hospital, surgical center, freest<strong>and</strong>ing imagingfacility, dental facility, or private <strong>of</strong>fice).There are other guidelines <strong>for</strong> specific situations <strong>and</strong>personnel that are beyond the scope <strong>of</strong> this document.Specifically, guidelines <strong>for</strong> the delivery <strong>of</strong> general anesthesia<strong>and</strong> monitored anesthesia care (sedation or analgesia),outside or within the operating room by anesthesiologistsor other practitioners functioning within adepartment <strong>of</strong> anesthesiology, are addressed by policiesdeveloped by the ASA <strong>and</strong> by individual departments <strong>of</strong>anesthesiology. 94 Also, guidelines <strong>for</strong> the sedation <strong>of</strong> patientsundergoing mechanical ventilation in a critical2588 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


care environment or <strong>for</strong> providing analgesia <strong>for</strong> patientspostoperatively, patients with chronic painful conditions,<strong>and</strong> hospice care are also beyond the scope <strong>of</strong> thisdocument.DEFINITION OF TERMS USED IN THIS REPORT● <strong>Pediatric</strong> patients: all patients through 21 years <strong>of</strong> age,as defined by the AAP.● Must/shall: an imperative need or duty that is essential,indispensable, or m<strong>and</strong>atory.● Should: the recommended need <strong>and</strong>/or duty.● May/could: freedom or liberty to follow a suggested orreasonable alternative.● Medical supervision/medical personnel: a currently licensedpractitioner <strong>of</strong> medicine, surgery, or dentistrytrained in the administration <strong>of</strong> medications used <strong>for</strong>procedural sedation <strong>and</strong> the management <strong>of</strong> complicationsassociated with these medications.● Encouraged: a suggested or reasonable action to betaken.● ASA physical status classification: guidelines <strong>for</strong> classifyingthe baseline health status according to the ASA(see Appendix 1).● Minimal sedation (<strong>for</strong>merly anxiolysis): a drug-inducedstate during which patients respond normally toverbal comm<strong>and</strong>s; although cognitive function <strong>and</strong>coordination may be impaired, ventilatory <strong>and</strong> cardiovascularfunctions are unaffected.● Moderate sedation (<strong>for</strong>merly conscious sedation orsedation/analgesia): a drug-induced depression <strong>of</strong>consciousness during which patients respond purposefullyto verbal comm<strong>and</strong>s (eg, “open your eyes,”either alone or accompanied by light tactile stimulation,such as a light tap on the shoulder or face, not asternal rub). For older patients, this level <strong>of</strong> sedationimplies an interactive state; <strong>for</strong> younger patients, ageappropriatebehaviors (eg, crying) occur <strong>and</strong> are expected.Reflex withdrawal, although a normal responseto a painful stimulus, is not considered as theonly age-appropriate purposeful response (ie, it mustbe accompanied by another response, such as pushingaway the painful stimulus, to confirm a higher cognitivefunction). With moderate sedation, no interventionis required to maintain a patent airway, <strong>and</strong> spontaneousventilation is adequate. Cardiovascularfunction is usually maintained. However, in the case<strong>of</strong> procedures that may themselves cause airway obstruction(eg, dental or endoscopic), the practitionermust recognize an obstruction <strong>and</strong> assist the patient inopening the airway. If the patient is not making spontaneousef<strong>for</strong>ts to open their airway to relieve theobstruction, then the patient should be considered tobe deeply sedated.● Deep sedation (deep sedation/analgesia): a drug-induceddepression <strong>of</strong> consciousness during which patientscannot be easily aroused but respond purposefully(see discussion <strong>of</strong> reflex withdrawal above) afterrepeated verbal or painful stimulation (eg, purposefullypushing away the noxious stimuli). The ability toindependently maintain ventilatory function may beimpaired. <strong>Patients</strong> may require assistance in maintaininga patent airway, <strong>and</strong> spontaneous ventilation maybe inadequate. Cardiovascular function is usuallymaintained. A state <strong>of</strong> deep sedation may be accompaniedby partial or complete loss <strong>of</strong> protective airwayreflexes.● General anesthesia: a drug-induced loss <strong>of</strong> consciousnessduring which patients are not arousable, even bypainful stimulation. The ability to independentlymaintain ventilatory function is <strong>of</strong>ten impaired. <strong>Patients</strong><strong>of</strong>ten require assistance in maintaining a patentairway, <strong>and</strong> positive-pressure ventilation may be requiredbecause <strong>of</strong> depressed spontaneous ventilationor drug-induced depression <strong>of</strong> neuromuscular function.Cardiovascular function may be impaired.GOALS OF SEDATIONThe goals <strong>of</strong> sedation in the pediatric patient <strong>for</strong> diagnostic<strong>and</strong> therapeutic procedures are to (1) guard thepatient’s safety <strong>and</strong> welfare; (2) minimize physical discom<strong>for</strong>t<strong>and</strong> pain; (3) control anxiety, minimize psychologicaltrauma, <strong>and</strong> maximize the potential <strong>for</strong> amnesia;(4) control behavior <strong>and</strong>/or movement to allow the safecompletion <strong>of</strong> the procedure; <strong>and</strong> (5) return the patientto a state in which safe discharge from medical supervision,as determined by recognized criteria, is possible(Appendix 2).These goals can best be achieved by selecting the lowestdose <strong>of</strong> drug with the highest therapeutic index <strong>for</strong> theprocedure. It is beyond the scope <strong>of</strong> this document tospecify which drugs are appropriate <strong>for</strong> which procedures;however, the selection <strong>of</strong> the fewest number <strong>of</strong> drugs <strong>and</strong>matching drug selection to the type <strong>and</strong> goal <strong>of</strong> the procedureare essential <strong>for</strong> safe practice. 53,88,91–93,95–97 For example,analgesic medications such as opioids are indicated <strong>for</strong>painful procedures. For nonpainful procedures, such ascomputed tomography or MRI, sedatives/hypnotics arepreferred. When both sedation <strong>and</strong> analgesia are desirable(eg, fracture reduction), either single agents with analgesic/sedative properties or combination regimens are commonlyused. Anxiolysis <strong>and</strong> amnesia are additional goalsthat should be considered in selection <strong>of</strong> agents <strong>for</strong> particularpatients. However, the potential <strong>for</strong> an adverse outcomemay be increased when 3 or more sedating medicationsare administered. 45,98 Knowledge <strong>of</strong> each drug’s time<strong>of</strong> onset, peak response, <strong>and</strong> duration <strong>of</strong> action is essential.Although the concept <strong>of</strong> titration <strong>of</strong> drug to effect is critical,one must know whether the previous dose has taken fullPEDIATRICS Volume 118, Number 6, December 2006 2589Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


effect be<strong>for</strong>e administering additional drug. Such managementwill improve safety <strong>and</strong> outcomes. Drugs with longdurations <strong>of</strong> action (eg, chloral hydrate, intramuscular pentobarbital,phenothiazines) will require longer periods <strong>of</strong>observation even after the child achieves currently usedrecovery <strong>and</strong> discharge criteria. 45,99,100 This concept is particularlyimportant <strong>for</strong> infants <strong>and</strong> toddlers transported incar safety seats who are at risk <strong>of</strong> resedation after dischargebecause <strong>of</strong> residual prolonged drug effects with the potential<strong>for</strong> airway obstruction. 45,46GENERAL GUIDELINESC<strong>and</strong>idates<strong>Patients</strong> who are in ASA classes I <strong>and</strong> II (Appendix 1) arefrequently considered appropriate c<strong>and</strong>idates <strong>for</strong> minimal,moderate, or deep sedation. Children in ASA classesIII <strong>and</strong> IV, children with special needs, <strong>and</strong> those withanatomic airway abnormalities or extreme tonsillar hypertrophypresent issues that require additional <strong>and</strong> individualconsideration, particularly <strong>for</strong> moderate <strong>and</strong>deep sedation. 51 Practitioners are encouraged to consultwith appropriate subspecialists <strong>and</strong>/or an anesthesiologist<strong>for</strong> patients at increased risk <strong>of</strong> experiencing adversesedation events because <strong>of</strong> their underlying medical/surgical conditions.Responsible PersonThe pediatric patient shall be accompanied to <strong>and</strong> fromthe treatment facility by a parent, legal guardian, orother responsible person. It is preferable to have 2 ormore adults accompany children who are still in carsafety seats if transportation to <strong>and</strong> from a treatmentfacility is provided by one <strong>of</strong> the adults. 101FacilitiesThe practitioner who uses sedation must have immediatelyavailable facilities, personnel, <strong>and</strong> equipment tomanage emergency <strong>and</strong> rescue situations. The mostcommon serious complications <strong>of</strong> sedation involve compromise<strong>of</strong> the airway or depressed respirations resultingin airway obstruction, hypoventilation, hypoxemia, <strong>and</strong>apnea. Hypotension <strong>and</strong> cardiopulmonary arrest mayoccur, usually from inadequate recognition <strong>and</strong> treatment<strong>of</strong> respiratory compromise. Other rare complicationsmay also include seizures <strong>and</strong> allergic reactions.Facilities that provide pediatric sedation should monitor<strong>for</strong>, <strong>and</strong> be prepared to treat, such complications.Back-up Emergency ServicesA protocol <strong>for</strong> access to back-up emergency services shallbe clearly identified with an outline <strong>of</strong> the proceduresnecessary <strong>for</strong> immediate use. For nonhospital facilities, aprotocol <strong>for</strong> ready access to ambulance service <strong>and</strong> immediateactivation <strong>of</strong> the EMS system <strong>for</strong> life-threateningcomplications must be established <strong>and</strong> maintained. Itshould be understood that the availability <strong>of</strong> EMS servicesdoes not replace the practitioner’s responsibility toprovide initial rescue in managing life-threatening complications.On-Site <strong>Monitoring</strong> <strong>and</strong> Rescue EquipmentAn emergency cart or kit must be immediately accessible.This cart or kit must contain equipment to providethe necessary age- <strong>and</strong> size-appropriate drugs <strong>and</strong> equipmentto resuscitate a nonbreathing <strong>and</strong> unconsciouschild. The contents <strong>of</strong> the kit must allow <strong>for</strong> the provision<strong>of</strong> continuous life support while the patient is beingtransported to a medical facility or to another areawithin a medical facility. All equipment <strong>and</strong> drugs mustbe checked <strong>and</strong> maintained on a scheduled basis (seeAppendices 3 <strong>and</strong> 4 <strong>for</strong> suggested drugs <strong>and</strong> emergencylife support equipment to consider be<strong>for</strong>e the need <strong>for</strong>rescue occurs). <strong>Monitoring</strong> devices, such as electrocardiography(ECG) machines, pulse oximeters (with sizeappropriateoximeter probes), end-tidal carbon dioxidemonitors, <strong>and</strong> defibrillators (with size-appropriate defibrillatorpaddles), must have a safety <strong>and</strong> function checkon a regular basis as required by local or state regulation.DocumentationDocumentation be<strong>for</strong>e sedation shall include, but not belimited to, the guidelines that follow.1. In<strong>for</strong>med consent: the patient record shall documentthat appropriate in<strong>for</strong>med consent was obtained accordingto local, state, <strong>and</strong> institutional requirements.1022. Instructions <strong>and</strong> in<strong>for</strong>mation provided to the responsibleperson: the practitioner shall provide verbal<strong>and</strong>/or written instructions to the responsible person.In<strong>for</strong>mation shall include objectives <strong>of</strong> the sedation<strong>and</strong> anticipated changes in behavior during <strong>and</strong> aftersedation. Special instructions shall be given to theresponsible adult <strong>for</strong> infants <strong>and</strong> toddlers who will betransported home in a car safety seat regarding theneed to carefully observe the child’s head position toavoid airway obstruction. Transportation in a carsafety seat poses a particular risk <strong>for</strong> infants who havereceived medications known to have a long half-life,such as chloral hydrate, intramuscular pentobarbital,or phenothiazine. 45,46,100,103 Consideration <strong>for</strong> a longerperiod <strong>of</strong> observation shall be given if the responsibleperson’s ability to observe the child is limited (eg,only 1 adult who also has to drive). Another indication<strong>for</strong> prolonged observation would be a child withan anatomic airway problem or a severe underlyingmedical condition. A 24-hour telephone number <strong>for</strong>the practitioner or his or her associates shall be providedto all patients <strong>and</strong> their families. Instructionsshall include limitations <strong>of</strong> activities <strong>and</strong> appropriatedietary precautions.2590 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


Dietary PrecautionsAgents used <strong>for</strong> sedation have the potential to impairprotective airway reflexes, particularly during deep sedation.Although a rare occurrence, pulmonary aspirationmay occur if the child regurgitates <strong>and</strong> cannot protecthis or her airway. There<strong>for</strong>e, it is prudent that,be<strong>for</strong>e sedation, the practitioner evaluate preceding food<strong>and</strong> fluid intake. It is likely that the risk <strong>of</strong> aspirationduring procedural sedation differs from that during generalanesthesia involving tracheal intubation or otherairway manipulation. 104,105 However, because the absoluterisk <strong>of</strong> aspiration during procedural sedation is notyet known, guidelines <strong>for</strong> fasting periods be<strong>for</strong>e electivesedation should generally follow those used <strong>for</strong> electivegeneral anesthesia. For emergency procedures in childrenwho have not fasted, the risks <strong>of</strong> sedation <strong>and</strong> thepossibility <strong>of</strong> aspiration must be balanced against thebenefits <strong>of</strong> per<strong>for</strong>ming the procedure promptly (see below).Additional research is needed to better elucidatethe relationships between various fasting intervals <strong>and</strong>sedation complications.Be<strong>for</strong>e Elective SedationChildren receiving sedation <strong>for</strong> elective proceduresshould generally follow the same fasting guidelines asthose <strong>for</strong> general anesthesia (Table 1). It is permissible<strong>for</strong> routine necessary medications to be taken with a sip<strong>of</strong> water on the day <strong>of</strong> the procedure.TABLE 1 Appropriate Intake <strong>of</strong> Food <strong>and</strong> Liquids Be<strong>for</strong>e ElectiveSedationIngested MaterialMinimum FastingPeriod, hClear liquids: water, fruit juices without2pulp, carbonated beverages, clear tea,black c<strong>of</strong>feeBreast milk 4Infant <strong>for</strong>mula 6Nonhuman milk: because nonhuman milk6is similar to solids in gastric emptyingtime, the amount ingested must beconsidered when determining anappropriate fasting periodLight meal: a light meal typically consists6<strong>of</strong> toast <strong>and</strong> clear liquids. Meals thatinclude fried or fatty foods or meat mayprolong gastric emptying time; boththe amount <strong>and</strong> type <strong>of</strong> foods ingestedmust be considered when determiningan appropriate fasting periodSource: American Society <strong>of</strong> Anesthesiologists. Practice guidelines <strong>for</strong> preoperative fasting <strong>and</strong>the use <strong>of</strong> pharmacologic agents to reduce the risk <strong>of</strong> pulmonary aspiration: application tohealthy patients undergoing elective procedures—a report <strong>of</strong> the American Society <strong>of</strong> Anesthesiologists.Available at: www.asahq.org/publicationsAndServices/NPO.pdf.Be<strong>for</strong>e Emergency SedationThe practitioner must always balance the possible risks<strong>of</strong> sedating nonfasted patients with the benefits <strong>and</strong>necessity <strong>for</strong> completing the procedure. In this circumstance,the use <strong>of</strong> sedation must be preceded by anevaluation <strong>of</strong> food <strong>and</strong> fluid intake. There are few publishedstudies with adequate statistical power to provideguidance to the practitioner regarding safety or risk <strong>of</strong>pulmonary aspiration <strong>of</strong> gastric contents during proceduralsedation. 104–109 When protective airway reflexes arelost, gastric contents may be regurgitated into the airway.There<strong>for</strong>e, patients with a history <strong>of</strong> recent oralintake or with other known risk factors, such as trauma,decreased level <strong>of</strong> consciousness, extreme obesity, pregnancy,or bowel motility dysfunction, require carefulevaluation be<strong>for</strong>e administration <strong>of</strong> sedatives. Whenproper fasting has not been ensured, the increased risks<strong>of</strong> sedation must be carefully weighed against its benefits,<strong>and</strong> the lightest effective sedation should be used.The use <strong>of</strong> agents with less risk <strong>of</strong> depressing protectiveairway reflexes may be preferred. 110 Some emergencypatients requiring deep sedation may require protection<strong>of</strong> the airway be<strong>for</strong>e sedation.Use <strong>of</strong> Immobilization DevicesImmobilization devices such as papoose boards must beapplied in such a way as to avoid airway obstruction orchest restriction. The child’s head position <strong>and</strong> respiratoryexcursions should be checked frequently to ensureairway patency. If an immobilization device is used, ah<strong>and</strong> or foot should be kept exposed, <strong>and</strong> the childshould never be left unattended. If sedating medicationsare administered in conjunction with an immobilizationdevice, monitoring must be used at a level consistentwith the level <strong>of</strong> sedation achieved.Documentation at the Time <strong>of</strong> Sedation1. Health evaluation: be<strong>for</strong>e sedation, a health evaluationshall be per<strong>for</strong>med by an appropriately licensedpractitioner <strong>and</strong> reviewed by the sedation team at thetime <strong>of</strong> treatment <strong>for</strong> possible interval changes. Thepurpose <strong>of</strong> this evaluation is to not only documentbaseline status but also determine if patients presentspecific risk factors that may warrant additional consultationbe<strong>for</strong>e sedation. This evaluation will alsoscreen out patients whose sedation will require moreadvanced airway or cardiovascular managementskills or alterations in the doses or types <strong>of</strong> medicationsused <strong>for</strong> procedural sedation.A new concern <strong>for</strong> the practitioner is the widespreaduse <strong>of</strong> medications that may interfere withdrug absorption or metabolism <strong>and</strong>, there<strong>for</strong>e, enhanceor shorten the effect time <strong>of</strong> sedating medications.Herbal medicines (eg, St John’s wort or echinacea),may alter drug pharmacokinetics throughinhibition <strong>of</strong> the cytochrome P450 system, resultingin prolonged drug effect <strong>and</strong> altered (increased ordecreased) blood drug concentrations. 111–116 Kava mayincrease the effects <strong>of</strong> sedatives by potentiatingPEDIATRICS Volume 118, Number 6, December 2006 2591Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


-aminobutyric acid inhibitory neurotransmission,<strong>and</strong> valerian may itself produce sedation that apparentlyis mediated through modulation <strong>of</strong> -aminobutyricacid neurotransmission <strong>and</strong> receptor function.117,118 Drugs such as erythromycin, cimetidine,<strong>and</strong> others may also inhibit the cytochrome P450system, resulting in prolonged sedation with midazolamas well as other medications competing <strong>for</strong> thesame enzyme systems. 119–122 Medications used to treatHIV infection, some anticonvulsants, <strong>and</strong> some psychotropicmedications may also produce clinically importantdrug-drug interactions. 123–125 There<strong>for</strong>e, carefullyobtaining a drug history is a vital part <strong>of</strong> the safe sedation<strong>of</strong> children. The clinician should consult varioussources (a pharmacist, textbooks, online services, orh<strong>and</strong>held databases) <strong>for</strong> specific in<strong>for</strong>mation on druginteractions. 126The health evaluation should include:● obtaining age <strong>and</strong> weight● obtaining a health history, including (1) allergies<strong>and</strong> previous allergic or adverse drug reactions; (2)medication/drug history, including dosage, time,route, <strong>and</strong> site <strong>of</strong> administration <strong>for</strong> prescription,over-the-counter, herbal, or illicit drugs; (3) relevantdiseases, physical abnormalities, <strong>and</strong> neurologicimpairment that might increase the potential<strong>for</strong> airway obstruction, such as a history <strong>of</strong> snoringor obstructive sleep apnea 127,128 ; (4) pregnancy status;(5) a summary <strong>of</strong> previous relevant hospitalizations;(6) history <strong>of</strong> sedation or general anesthesia<strong>and</strong> any complications or unexpected responses;<strong>and</strong> (7) relevant family history, particularly thatrelated to anesthesia● a review <strong>of</strong> systems with a special focus on abnormalities<strong>of</strong> cardiac, pulmonary, renal, or hepaticfunction that might alter the child’s expected responsesto sedating/analgesic medications● determination <strong>of</strong> vital signs, including heart rate,blood pressure, respiratory rate, <strong>and</strong> temperature(<strong>for</strong> some children who are very upset or noncooperative,this may not be possible, <strong>and</strong> a noteshould be written to document this occurrence)● a physical examination, including a focused evaluation<strong>of</strong> the airway (tonsillar hypertrophy, abnormalanatomy [eg, m<strong>and</strong>ibular hypoplasia]) to determineif there is an increased risk <strong>of</strong> airwayobstruction 54,129,130● a physical status evaluation (ASA classification [seeAppendix 1])● obtaining name, address, <strong>and</strong> telephone number <strong>of</strong>the child’s medical homeFor hospitalized patients, the current hospitalrecord may suffice <strong>for</strong> adequate documentation <strong>of</strong>presedation health; however, a brief note shall bewritten documenting that the chart was reviewed,positive findings were noted, <strong>and</strong> a management planwas <strong>for</strong>mulated. If the clinical or emergency condition<strong>of</strong> the patient precludes acquiring complete in<strong>for</strong>mationbe<strong>for</strong>e sedation, this health evaluationshould be obtained as soon as is feasible.2. Prescriptions: when prescriptions are used <strong>for</strong> sedation,a copy <strong>of</strong> the prescription or a note describingthe content <strong>of</strong> the prescription should be in the patient’schart along with a description <strong>of</strong> the instructionsthat were given to the responsible person. Prescriptionmedications intended to accomplish proceduralsedation must not be administered without the benefit <strong>of</strong>direct supervision by trained medical personnel. Administration<strong>of</strong> sedating medications at home poses anunacceptable risk, particularly <strong>for</strong> infants <strong>and</strong> preschool-agedchildren traveling in car safety seats. 46Documentation During TreatmentThe patient’s chart shall contain a time-based record thatincludes the name, route, site, time, dosage, <strong>and</strong> patienteffect <strong>of</strong> administered drugs. Be<strong>for</strong>e sedation, a “timeout” should be per<strong>for</strong>med to confirm the patient’s name,procedure to be per<strong>for</strong>med, <strong>and</strong> site <strong>of</strong> the procedure. 43During administration, the inspired concentrations <strong>of</strong>oxygen <strong>and</strong> inhalation sedation agents <strong>and</strong> the duration<strong>of</strong> their administration shall be documented. Be<strong>for</strong>e drugadministrations, special attention must be paid to calculation<strong>of</strong> dosage (ie, mg/kg). The patient’s chart shallcontain documentation at the time <strong>of</strong> treatment that thepatient’s level <strong>of</strong> consciousness <strong>and</strong> responsiveness,heart rate, blood pressure, respiratory rate, <strong>and</strong> oxygensaturation were monitored until the patient attainedpredetermined discharge criteria (see Appendix 2). Avariety <strong>of</strong> sedation-scoring systems are available <strong>and</strong>may aid this process. 70,100 Adverse events <strong>and</strong> their treatmentshall be documented.Documentation After TreatmentThe time <strong>and</strong> condition <strong>of</strong> the child at discharge from thetreatment area or facility shall be documented; thisshould include documentation that the child’s level <strong>of</strong>consciousness <strong>and</strong> oxygen saturation in room air havereturned to a state that is safe <strong>for</strong> discharge by recognizedcriteria (see Appendix 2). <strong>Patients</strong> receiving supplementaloxygen be<strong>for</strong>e the procedure should have asimilar oxygen need after the procedure. Because somesedation medications are known to have a long half-life<strong>and</strong> may delay a patient’s complete return to baseline orpose the risk <strong>of</strong> resedation, 45,103,131,132 some patients mightbenefit from a longer period <strong>of</strong> less-intense observation(eg, a step-down observation area) be<strong>for</strong>e dischargefrom medical supervision. 133 Several scales to evaluaterecovery have been devised <strong>and</strong> validated. 70,134,135 A re-2592 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


cently described <strong>and</strong> simple evaluation tool may be theability <strong>of</strong> the infant or child to remain awake <strong>for</strong> at least20 minutes when placed in a quiet environment. 100CONTINUOUS QUALITY IMPROVEMENTThe essence <strong>of</strong> medical error reduction is a careful examination<strong>of</strong> index events <strong>and</strong> root-cause analysis <strong>of</strong>how the event could be avoided in the future. 136–140There<strong>for</strong>e, each facility should maintain records thattrack adverse events such as desaturation, apnea, laryngospasm,the need <strong>for</strong> airway interventions includingjaw thrust or positive pressure ventilation, prolongedsedation, unanticipated use <strong>of</strong> reversal agents, unintendedor prolonged hospital admission, <strong>and</strong> unsatisfactorysedation/analgesia/anxiolysis. Such events can thenbe examined <strong>for</strong> assessment <strong>of</strong> risk reduction <strong>and</strong> improvementin patient satisfaction.PREPARATION AND SETUP FOR SEDATION PROCEDURESPart <strong>of</strong> the safety net <strong>of</strong> sedation is to use a systematicapproach so as to not overlook having an importantdrug, piece <strong>of</strong> equipment, or monitor immediately availableat the time <strong>of</strong> a developing emergency. To avoid thisproblem, it is helpful to use an acronym that allows thesame setup <strong>and</strong> checklist <strong>for</strong> every procedure. A commonlyused acronym that is useful in planning <strong>and</strong>preparation <strong>for</strong> a procedure is SOAPME:S (suction)—size-appropriate suction catheters <strong>and</strong> a functioningsuction apparatus (eg, Yankauer-type suction)O (oxygen)—adequate oxygen supply <strong>and</strong> functioningflow meters/other devices to allow its deliveryA (airway)—size-appropriate airway equipment (nasopharyngeal<strong>and</strong> oropharyngeal airways, laryngoscopeblades [checked <strong>and</strong> functioning], endotracheal tubes,stylets, face mask, bag-valve-mask or equivalent device[functioning])P (pharmacy)—all the basic drugs needed to support lifeduring an emergency, including antagonists as indicatedM (monitors)—functioning pulse oximeter with sizeappropriateoximeter probes 141,142 <strong>and</strong> other monitors asappropriate <strong>for</strong> the procedure (eg, noninvasive blood pressure,end-tidal carbon dioxide, ECG, stethoscope)E (equipment)—special equipment or drugs <strong>for</strong> a particularcase (eg, defibrillator)SPECIFIC GUIDELINES FOR INTENDED LEVEL OF SEDATIONMinimal SedationMinimal sedation (<strong>for</strong>merly anxiolysis) is a drug-inducedstate during which patients respond normally toverbal comm<strong>and</strong>s. Although cognitive function <strong>and</strong> coordinationmay be impaired, ventilatory <strong>and</strong> cardiovascularfunctions are unaffected. Children who have receivedminimal sedation generally will not require morethan observation <strong>and</strong> intermittent assessment <strong>of</strong> theirlevel <strong>of</strong> sedation. Some children will become moderatelysedated despite the intended level <strong>of</strong> minimal sedation;should this occur, the guidelines <strong>for</strong> moderate sedationwill apply. 56Moderate SedationModerate sedation (<strong>for</strong>merly conscious sedation or sedation/analgesia)is a drug-induced depression <strong>of</strong> consciousnessduring which patients respond purposefullyto verbal comm<strong>and</strong>s or light tactile stimulation (see“Definition <strong>of</strong> Terms Used in This Report”). No interventionsare required to maintain a patent airway, <strong>and</strong>spontaneous ventilation is adequate. Cardiovascularfunction is usually maintained. The caveat that loss <strong>of</strong>consciousness should be unlikely is a particularly importantaspect <strong>of</strong> the definition <strong>of</strong> moderate sedation. Thedrugs <strong>and</strong> techniques used should carry a margin <strong>of</strong>safety wide enough to render unintended loss <strong>of</strong> consciousnesshighly unlikely. Because the patient who receivesmoderate sedation may progress into a state <strong>of</strong>deep sedation <strong>and</strong> obtundation, the practitioner shouldbe prepared to increase the level <strong>of</strong> vigilance correspondingto what is necessary <strong>for</strong> deep sedation. 56PersonnelThe PractitionerThe practitioner responsible <strong>for</strong> the treatment <strong>of</strong> thepatient <strong>and</strong>/or the administration <strong>of</strong> drugs <strong>for</strong> sedationmust be competent to use such techniques, provide thelevel <strong>of</strong> monitoring provided in these guidelines, <strong>and</strong>manage complications <strong>of</strong> these techniques (ie, to be ableto rescue the patient). Because the level <strong>of</strong> intendedsedation may be exceeded, the practitioner must be sufficientlyskilled to provide rescue should the childprogress to a level <strong>of</strong> deep sedation. The practitionermust be trained in, <strong>and</strong> capable <strong>of</strong> providing, at theminimum, bag-valve-mask ventilation to be able tooxygenate a child who develops airway obstruction orapnea. Training in, <strong>and</strong> maintenance <strong>of</strong>, advanced pediatricairway skills is required; regular skills rein<strong>for</strong>cementis strongly encouraged.Support PersonnelThe use <strong>of</strong> moderate sedation shall include provision<strong>of</strong> a person, in addition to the practitioner, whose responsibilityis to monitor appropriate physiologic parameters<strong>and</strong> to assist in any supportive or resuscitationmeasures if required. This individual may also be responsible<strong>for</strong> assisting with interruptible patient-relatedtasks <strong>of</strong> short duration. 44 This individual must be trainedin <strong>and</strong> capable <strong>of</strong> providing pediatric basic life support.The support person shall have specific assignments inthe event <strong>of</strong> an emergency <strong>and</strong> current knowledge <strong>of</strong> theemergency cart inventory. The practitioner <strong>and</strong> all ancillarypersonnel should participate in periodic reviews<strong>and</strong> practice drills <strong>of</strong> the facility’s emergency protocol toensure proper function <strong>of</strong> the equipment <strong>and</strong> coordination<strong>of</strong> staff roles in such emergencies.<strong>Monitoring</strong> <strong>and</strong> DocumentationBaselineBe<strong>for</strong>e administration <strong>of</strong> sedative medications, a baselinedetermination <strong>of</strong> vital signs shall be documented.PEDIATRICS Volume 118, Number 6, December 2006 2593Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


For some children who are very upset or noncooperative,this may not be possible, <strong>and</strong> a note should bewritten to document this happenstance.During the ProcedureThe practitioner shall document the name, route, site,time <strong>of</strong> administration, <strong>and</strong> dosage <strong>of</strong> all drugs administered.There shall be continuous monitoring <strong>of</strong> oxygensaturation <strong>and</strong> heart rate <strong>and</strong> intermittent recording <strong>of</strong>respiratory rate <strong>and</strong> blood pressure; these should berecorded in a time-based record. Restraining devicesshould be checked to prevent airway obstruction orchest restriction. If a restraint device is used, a h<strong>and</strong> orfoot should be kept exposed. The child’s head positionshould be checked frequently to ensure airway patency.A functioning suction apparatus must be present.After the ProcedureThe child who has received moderate sedation mustbe observed in a suitably equipped recovery facility (ie,the facility must have functioning suction apparatus aswell as the capacity to deliver more than 90% oxygen<strong>and</strong> positive-pressure ventilation [eg, bag <strong>and</strong> mask withoxygen capacity as described previously]). The patient’svital signs should be recorded at specific intervals. If thepatient is not fully alert, oxygen saturation <strong>and</strong> heartrate monitoring shall be used continuously until appropriatedischarge criteria are met (see Appendix 2). Becausesedation medications with a long half-life maydelay the patient’s complete return to baseline or posethe risk <strong>of</strong> resedation, some patients might benefit froma longer period <strong>of</strong> less-intense observation (eg, a stepdownobservation area in which multiple patients can beobserved simultaneously) be<strong>for</strong>e discharge from medicalsupervision (see also “Documentation” <strong>for</strong> instructionsto families). 45,103,131,132 A recently described <strong>and</strong> simpleevaluation tool may be the ability <strong>of</strong> the infant or childto remain awake <strong>for</strong> at least 20 minutes when placed ina quiet environment. 100 <strong>Patients</strong> who have received reversalagents, such as flumazenil or naloxone, will alsorequire a longer period <strong>of</strong> observation, because the duration<strong>of</strong> the drugs administered may exceed the duration<strong>of</strong> the antagonist, which can lead to resedation.Deep SedationDeep sedation is a drug-induced depression <strong>of</strong> consciousnessduring which patients cannot be easilyaroused but respond purposefully after repeated verbalor painful stimulation (see “Definition <strong>of</strong> Terms Used inThis Report”). The state <strong>and</strong> risks <strong>of</strong> deep sedation maybe indistinguishable from those <strong>of</strong> general anesthesia.PersonnelThere must be 1 person available whose only responsibilityis to constantly observe the patient’s vital signs,airway patency, <strong>and</strong> adequacy <strong>of</strong> ventilation <strong>and</strong> to eitheradminister drugs or direct their administration. Atleast 1 individual must be present who is trained in, <strong>and</strong>capable <strong>of</strong>, providing advanced pediatric life support <strong>and</strong>who is skilled in airway management <strong>and</strong> cardiopulmonaryresuscitation; training in pediatric advanced lifesupport is required.EquipmentIn addition to the equipment previously cited <strong>for</strong> moderatesedation, an ECG monitor <strong>and</strong> a defibrillator <strong>for</strong>use in pediatric patients should be readily available.Vascular Access<strong>Patients</strong> receiving deep sedation should have an intravenousline placed at the start <strong>of</strong> the procedure or havea person skilled in establishing vascular access in pediatricpatients immediately available.<strong>Monitoring</strong>A competent individual shall observe the patient continuously.The monitoring shall include all parameters described<strong>for</strong> moderate sedation. Vital signs, including oxygensaturation <strong>and</strong> heart rate, must be documented atleast every 5 minutes in a time-based record. The use <strong>of</strong>a precordial stethoscope or capnograph <strong>for</strong> patients whoare difficult to observe (eg, during MRI or in a darkenedroom) to aid in monitoring adequacy <strong>of</strong> ventilation isencouraged. 143 The practitioner shall document thename, route, site, time <strong>of</strong> administration, <strong>and</strong> dosage <strong>of</strong>all drugs administered. The inspired concentrations <strong>of</strong>inhalation sedation agents <strong>and</strong> oxygen <strong>and</strong> the duration<strong>of</strong> administration shall be documented.Postsedation CareThe facility <strong>and</strong> procedures followed <strong>for</strong> postsedationcare shall con<strong>for</strong>m to those described <strong>for</strong> moderate sedation.SPECIAL CONSIDERATIONSLocal Anesthetic AgentsAll local anesthetic agents are cardiac depressants <strong>and</strong>may cause central nervous system excitation or depression.Particular attention should be paid to dosage insmall children. 64,66 To ensure that the patient will notreceive an excessive dose, the maximum allowable safedosage (eg, mg/kg) should be calculated be<strong>for</strong>e administration.There may be enhanced sedative effects whenthe highest recommended doses <strong>of</strong> local anesthetic drugsare used in combination with other sedatives or narcotics(see Tables 2 <strong>and</strong> 3 <strong>for</strong> limits <strong>and</strong> conversion tables <strong>of</strong>commonly used local anesthetics). 64,144–157 In general,when administering local anesthetic drugs, the practitionershould aspirate frequently to minimize the likelihoodthat the needle is in a blood vessel; lower dosesshould be used when injecting into vascular tissues. 1582594 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


TABLE 2Local AnestheticCommonly Used Local Anesthetic Agents: Doses,Duration, <strong>and</strong> CalculationsMaximum Dose WithEpinephrine, mg/kg aDuration <strong>of</strong> Action,min bMedical DentalEstersProcaine 10.0 6 60–90Chloroprocaine 20.0 12 30–60Tetracaine 1.5 1 180–600AmidesLidocaine 7.0 4.4 90–200Mepivacaine 7.0 4.4 120–240Bupivacaine 3.0 1.3 180–600Levobupivacaine 3.0 2 180–600Ropivacaine 3.0 2 180–600Articaine 7 60–230Maximum recommended doses <strong>and</strong> duration <strong>of</strong> action are shown. Note that lower dosesshould be used in very vascular areas.aThese are maximum doses <strong>of</strong> local anesthetics combined with epinephrine; lower doses arerecommended when used without epinephrine. Doses <strong>of</strong> amides should be decreased by 30%<strong>for</strong> infants younger than 6 months. When lidocaine is being administered intravascularly (eg,during intravenous regional anesthesia), the dose should be decreased to 3 to 5 mg/kg; longactinglocal anesthetic agents should not be used <strong>for</strong> intravenous regional anesthesia.bDuration <strong>of</strong> action depends on concentration, total dose, <strong>and</strong> site <strong>of</strong> administration; use <strong>of</strong>epinephrine; <strong>and</strong> the patient’s age.Pulse OximetryThe new-generation pulse oximeters are less susceptible tomotion artifacts <strong>and</strong> may be more useful than older oximetersthat do not contain the updated s<strong>of</strong>tware. 159–163 Oximetersthat change tone with changes in hemoglobin saturationprovide immediate aural warning to everyone withinhearing distance. It is essential that any oximeter probe isproperly positioned; clip-on devices are prone to easy displacement,which may produce artifactual data (underestimationor overestimation <strong>of</strong> oxygen saturation). 141,142CapnographyExpired carbon dioxide monitoring is valuable to diagnosethe simple presence or absence <strong>of</strong> respirations,airway obstruction, or respiratory depression, particularlyin patients sedated in less-accessible locations, suchas MRI or computerized axial tomography devices ordarkened rooms. 47,49,50,143,164–173 The use <strong>of</strong> expired carbondioxide monitoring devices is encouraged <strong>for</strong> sedatedchildren, particularly in situations where other means <strong>of</strong>assessing the adequacy <strong>of</strong> ventilation are limited. Severalmanufacturers have produced nasal cannulae that allowsimultaneous delivery <strong>of</strong> oxygen <strong>and</strong> measurement <strong>of</strong>expired carbon dioxide values. 164,165 Although these devicescan have a high degree <strong>of</strong> false-positive alarms,they are also very accurate <strong>for</strong> the detection <strong>of</strong> completeairway obstruction or apnea. 166,168,173Adjuncts to Airway <strong>Management</strong> <strong>and</strong> ResuscitationThe vast majority <strong>of</strong> sedation complications can bemanaged with simple maneuvers, such as providingsupplemental oxygen, opening the airway, suctioning,<strong>and</strong> using bag-mask-valve ventilation. Occasionally,TABLE 3 Local Anesthetic Percent Concentration: Conversion tomg/mLConcentration, %mg/mL3.0 30.02.5 25.02.0 20.01.0 10.00.5 5.00.25 2.50.125 1.25endotracheal intubation is required <strong>for</strong> more prolongedventilatory support. In addition to st<strong>and</strong>ardendotracheal intubation techniques, a number <strong>of</strong> newdevices are available <strong>for</strong> the management <strong>of</strong> patientswith abnormal airway anatomy or airway obstruction.Examples include the laryngeal mask airway (LMA),the cuffed oropharyngeal airway, <strong>and</strong> a variety <strong>of</strong> kitsto per<strong>for</strong>m an emergency cricothyrotomy.The largest clinical experience in pediatrics is with theLMA, which is available in a variety <strong>of</strong> sizes <strong>and</strong> caneven be used in neonates. Use <strong>of</strong> the LMA is now beingintroduced into advanced airway training courses, <strong>and</strong>familiarity with insertion techniques can be life-saving.174,175 The LMA can also serve as a bridge to secureairway management in children with anatomic airwayabnormalities. 176,177 Practitioners are encouraged to gainexperience with these techniques as they become incorporatedinto pediatric advanced life support courses.An additional emergency device with which to becomefamiliar is the intraosseous needle. Intraosseous needles arealso available in several sizes <strong>and</strong> can be life-saving in therare situation when rapid establishment <strong>of</strong> intravenousaccess is not possible. Familiarity with the use <strong>of</strong> theseadjuncts <strong>for</strong> the management <strong>of</strong> emergencies can be obtainedby keeping current with resuscitation courses, suchas <strong>Pediatric</strong> Advanced Life Support <strong>and</strong> Advanced <strong>Pediatric</strong>Life Support or other approved programs.Patient SimulatorsAdvances in technology, particularly patient simulatorsthat allow a variety <strong>of</strong> programmed adverse events such asapnea, bronchospasm, laryngospasm, response to medicalinterventions, <strong>and</strong> printouts <strong>of</strong> physiologic parameters, arenow available. The use <strong>of</strong> such devices is encouraged tobetter train medical pr<strong>of</strong>essionals to respond more appropriately<strong>and</strong> effectively to rare events. 178–180<strong>Monitoring</strong> During MRIThe powerful magnetic field <strong>and</strong> the generation <strong>of</strong> radi<strong>of</strong>requency emissions necessitate the use <strong>of</strong> special equipmentto provide continuous patient monitoringthroughout the MRI procedure. Pulse oximeters capable<strong>of</strong> continuous function during scanning should be usedin any sedated or restrained pediatric patient. Thermalinjuries can result if appropriate precautions are notPEDIATRICS Volume 118, Number 6, December 2006 2595Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


taken; avoid coiling the oximeter wire <strong>and</strong> place theprobe as far from the magnetic coil as possible to diminishthe possibility <strong>of</strong> injury. Electrocardiogram monitoringduring MRI has been associated with thermal injury;special MRI-compatible ECG pads are essential to allowsafe monitoring. 181–184 Expired carbon dioxide monitoringis strongly encouraged in this setting.Nitrous OxideInhalation sedation/analgesia equipment that delivers nitrousoxide must have the capacity <strong>of</strong> delivering 100% <strong>and</strong>never less than 25% oxygen concentration at a flow rateappropriate to the size <strong>of</strong> the patient. Equipment that deliversvariable ratios <strong>of</strong> nitrous oxide to oxygen <strong>and</strong> thathas a delivery system that covers the mouth <strong>and</strong> nose mustbe used in conjunction with a calibrated <strong>and</strong> functionaloxygen analyzer. All nitrous oxide-to-oxygen inhalationdevices should be calibrated in accordance with appropriatestate <strong>and</strong> local requirements. Consideration should begiven to the National Institute <strong>of</strong> Occupational Safety <strong>and</strong>Health St<strong>and</strong>ards <strong>for</strong> the scavenging <strong>of</strong> waste gases. 185Newly constructed or reconstructed treatment facilities, especiallythose with piped-in nitrous oxide <strong>and</strong> oxygen,must have appropriate state or local inspections to certifyproper function <strong>of</strong> inhalation sedation/analgesia systemsbe<strong>for</strong>e any delivery <strong>of</strong> patient care.Nitrous oxide in oxygen with varying concentrationshas been successfully used <strong>for</strong> many years to provideanalgesia <strong>for</strong> a variety <strong>of</strong> painful procedures in children.15,186–210 The use <strong>of</strong> nitrous oxide <strong>for</strong> minimal sedationis defined as the administration <strong>of</strong> nitrous oxide(50% or less) with the balance as oxygen, without anyother sedative, narcotic, or other depressant drug be<strong>for</strong>eor concurrent with the nitrous oxide to an otherwisehealthy patient in ASA class I or II. The patient is able tomaintain verbal communication throughout the procedure.It should be noted that although local anestheticshave sedative properties, <strong>for</strong> purposes <strong>of</strong> this guideline,they are not considered sedatives in this circumstance. Ifnitrous oxide in oxygen is combined with other sedatingmedications, such as chloral hydrate, midazolam, or anopioid, or if nitrous oxide is used in concentrations morethan 50%, the likelihood <strong>for</strong> moderate or deep sedationincreases. 211,212 In this situation, the clinician must beprepared to institute the guidelines <strong>for</strong> moderate or deepsedation as indicated by the patient’s response. 213WORK GROUP ON SEDATIONPaul Casamassimo, DDS, MSCharles J. Coté, MDPatricia Crumrine, MDRichard L. Gorman, MDMary Hegenbarth, MDStephen Wilson, DMD, MA, PhDSTAFFRaymond J. Koteras, MHAREFERENCES1. Milnes AR. Intravenous procedural sedation: an alternative togeneral anesthesia in the treatment <strong>of</strong> early childhood caries.J Can Dent Assoc. 2003;69:298–3022. Law AK, Ng DK, Chan KK. Use <strong>of</strong> intramuscular ketamine <strong>for</strong>endoscopy sedation in children. Pediatr Int. 2003;45:180–1853. Rothermel LK. Newer pharmacologic agents <strong>for</strong> proceduralsedation <strong>of</strong> children in the emergency department: etomidate<strong>and</strong> prop<strong>of</strong>ol. Curr Opin Pediatr. 2003;15:200–2034. Flood RG, Krauss B. Procedural sedation <strong>and</strong> analgesia <strong>for</strong>children in the emergency department. Emerg Med Clin NorthAm. 2003;21:121–1395. Jaggar SI, Haxby E. Sedation, anaesthesia <strong>and</strong> monitoring <strong>for</strong>bronchoscopy. Paediatr Respir Rev. 2002;3:321–3276. de Blic J, Marchac V, Scheinmann P. Complications <strong>of</strong> flexiblebronchoscopy in children: prospective study <strong>of</strong> 1,328 procedures.Eur Respir J. 2002;20:1271–12767. Mason KP, Michna E, DiNardo JA, et al. Evolution <strong>of</strong> a protocol<strong>for</strong> ketamine-induced sedation as an alternative to generalanesthesia <strong>for</strong> interventional radiologic procedures inpediatric patients. Radiology. 2002;225:457–4658. Houpt M. Project USAP 2000: use <strong>of</strong> sedative agents by pediatricdentists—a 15-year follow-up survey. Pediatr Dent. 2002;24:289–2949. Vinson DR, Bradbury DR. Etomidate <strong>for</strong> procedural sedationin emergency medicine. Ann Emerg Med. 2002;39:592–59810. Everitt IJ, Barnett P. Comparison <strong>of</strong> two benzodiazepines used<strong>for</strong> sedation <strong>of</strong> children undergoing suturing <strong>of</strong> a laceration inan emergency department. Pediatr Emerg Care. 2002;18:72–7411. Karian VE, Burrows PE, Zurakowski D, Connor L, PoznauskisL, Park MK. The development <strong>of</strong> a pediatric radiology sedationprogram. Pediatr Radiol. 2002;32:348–35312. Kaplan RF, Yang CI. Sedation <strong>and</strong> analgesia in pediatric patients<strong>for</strong> procedures outside the operating room. AnesthesiolClin North America. 2002;20:181–19413. Wheeler DS, Jensen RA, Poss WB. A r<strong>and</strong>omized, blindedcomparison <strong>of</strong> chloral hydrate <strong>and</strong> midazolam sedation inchildren undergoing echocardiography. Clin Pediatr (Phila).2001;40:381–38714. Hain RD, Campbell C. Invasive procedures carried out inconscious children: contrast between North American <strong>and</strong>European paediatric oncology centres. Arch Dis Child. 2001;85:12–1515. Kennedy RM, Luhmann JD. Pharmacological management <strong>of</strong>pain <strong>and</strong> anxiety during emergency procedures in children.Paediatr Drugs. 2001;3:337–35416. Kanagasundaram SA, Lane LJ, Cavalletto BP, Keneally JP,Cooper MG. Efficacy <strong>and</strong> safety <strong>of</strong> nitrous oxide in alleviatingpain <strong>and</strong> anxiety during painful procedures. Arch Dis Child.2001;84:492–49517. Younge PA, Kendall JM. Sedation <strong>for</strong> children requiringwound repair: a r<strong>and</strong>omised controlled double blind comparison<strong>of</strong> oral midazolam <strong>and</strong> oral ketamine. Emerg Med J.2001;18:30–3318. Ljungman G, Gordh T, Sorensen S, Kreuger A. Lumbar puncturein pediatric oncology: conscious sedation vs. generalanesthesia. Med Pediatr Oncol. 2001;36:372–37919. Poe SS, Nolan MT, Dang D, et al. Ensuring safety <strong>of</strong> patientsreceiving sedation <strong>for</strong> procedures: evaluation <strong>of</strong> clinical practiceguidelines. Jt Comm J Qual Improv. 2001;27:28–4120. D’Agostino J, Terndrup TE. Chloral hydrate versus midazolam<strong>for</strong> sedation <strong>of</strong> children <strong>for</strong> neuroimaging: a r<strong>and</strong>omized clinicaltrial. Pediatr Emerg Care. 2000;16:1–42596 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


21. Green SM, Kuppermann N, Rothrock SG, Hummel CB, Ho M.Predictors <strong>of</strong> adverse events with intramuscular ketaminesedation in children. Ann Emerg Med. 2000;35:35–4222. Pena BM, Krauss B. Adverse events <strong>of</strong> procedural sedation<strong>and</strong> analgesia in a pediatric emergency department. AnnEmerg Med. 1999;34:483–49123. Hopkins KL, Davis PC, S<strong>and</strong>ers CL, Churchill LH. Sedation <strong>for</strong>pediatric imaging studies. Neuroimaging Clin N Am. 1999;9:1–1024. Bauman LA, Kish I, Baumann RC, Politis GD. <strong>Pediatric</strong> sedationwith analgesia. Am J Emerg Med. 1999;17:1–325. Bhatt-Mehta V, Rosen DA. Sedation in children: current concepts[published correction appears in Pharmacotherapy. 1998;18:1395]. Pharmacotherapy. 1998;18:790–80726. Morton NS, Oomen GJ. Development <strong>of</strong> a selection <strong>and</strong> monitoringprotocol <strong>for</strong> safe sedation <strong>of</strong> children. Paediatr Anaesth.1998;8:65–6827. Murphy MS. Sedation <strong>for</strong> invasive procedures in paediatrics.Arch Dis Child. 1997;77:281–28428. Webb MD, Moore PA. Sedation <strong>for</strong> pediatric dental patients.Dent Clin North Am. 2002;46:803–81429. Malviya S, Voepel-Lewis T, Tait AR, Merkel S. Sedation/analgesia <strong>for</strong> diagnostic <strong>and</strong> therapeutic procedures in children.J Perianesth Nurs. 2000;15:415–42230. Zempsky WT, Schechter NL. Office-based pain management:the 15-minute consultation. Pediatr Clin North Am. 2000;47:601–61531. Kennedy RM, Luhmann JD. The “ouchless emergencydepartment”: getting closer—advances in decreasing distressduring painful procedures in the emergency department. PediatrClin North Am. 1999;46:1215–124732. Rodriguez E, Jordan R. Contemporary trends in pediatricsedation <strong>and</strong> analgesia. Emerg Med Clin North Am. 2002;20:199–22233. Ruess L, O’Connor SC, Mikita CP, Creamer KM. Sedation <strong>for</strong>pediatric diagnostic imaging: use <strong>of</strong> pediatric <strong>and</strong> nursingresources as an alternative to a radiology department sedationteam. Pediatr Radiol. 2002;32:505–51034. Weiss S. Sedation <strong>of</strong> pediatric patients <strong>for</strong> nuclear medicineprocedures. Semin Nucl Med. 1993;23:190–19835. Wilson S. Pharmacologic behavior management <strong>for</strong> pediatricdental treatment. Pediatr Clin North Am. 2000;47:1159–117536. McCarty EC, Mencio GA, Green NE. Anesthesia <strong>and</strong> analgesia<strong>for</strong> the ambulatory management <strong>of</strong> fractures in children. JAmAcad Orthop Surg. 1999;7:81–9137. Egelh<strong>of</strong>f JC, Ball WS Jr, Koch BL, Parks TD. Safety <strong>and</strong>efficacy <strong>of</strong> sedation in children using a structured sedationprogram. AJR Am J Roentgenol. 1997;168:1259–126238. American Academy <strong>of</strong> <strong>Pediatric</strong>s, Committee on Drugs <strong>and</strong>Section on Anesthesiology. <strong>Guidelines</strong> <strong>for</strong> the elective use <strong>of</strong>conscious sedation, deep sedation, <strong>and</strong> general anesthesia inpediatric patients. <strong>Pediatric</strong>s. 1985;76:317–32139. American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry. <strong>Guidelines</strong> <strong>for</strong> theelective use <strong>of</strong> conscious sedation, deep sedation, <strong>and</strong> generalanesthesia in pediatric patients. ASDC J Dent Child. 1986;53:21–2240. American Academy <strong>of</strong> <strong>Pediatric</strong>s, Committee on Drugs.<strong>Guidelines</strong> <strong>for</strong> monitoring <strong>and</strong> management <strong>of</strong> pediatric patientsduring <strong>and</strong> after sedation <strong>for</strong> diagnostic <strong>and</strong> therapeuticprocedures. <strong>Pediatric</strong>s. 1992;89:1110–111541. American Academy <strong>of</strong> <strong>Pediatric</strong>s, Committee on Drugs.<strong>Guidelines</strong> <strong>for</strong> monitoring <strong>and</strong> management <strong>of</strong> pediatric patientsduring <strong>and</strong> after sedation <strong>for</strong> diagnostic <strong>and</strong> therapeuticprocedures: addendum. <strong>Pediatric</strong>s. 2002;110:836–83842. American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry, Ad Hoc Committeeon Sedation <strong>and</strong> Anesthesia. <strong>Guidelines</strong> on the Elective Use <strong>of</strong>Minimal, Moderate, <strong>and</strong> Deep Sedation <strong>and</strong> General Anesthesia <strong>for</strong><strong>Pediatric</strong> Dental <strong>Patients</strong>. Chicago, IL: American Academy <strong>of</strong><strong>Pediatric</strong> Dentistry; 2004. Available at: www.aapd.org/media/Policies<strong>Guidelines</strong>/GSedation.pdf. Accessed February 7,200643. Joint Commission on Accreditation <strong>of</strong> Healthcare Organizations.Comprehensive Accreditation Manual <strong>for</strong> Hospitals: The OfficialH<strong>and</strong>book by the JCAHO. Oakbrook Terrace, IL: JointCommission on Accreditation <strong>of</strong> Healthcare Organizations;200544. American Society <strong>of</strong> Anesthesiologists, Task Force on Sedation<strong>and</strong> Analgesia by Non-anesthesiologists. Practice guidelines<strong>for</strong> sedation <strong>and</strong> analgesia by non-anesthesiologists. Anesthesiology.2002;96:1004–101745. Coté CJ, Karl HW, Notterman DA, Weinberg JA, McCloskeyC. Adverse sedation events in pediatrics: analysis <strong>of</strong> medicationsused <strong>for</strong> sedation. <strong>Pediatric</strong>s. 2000;106:633–64446. Coté CJ, Notterman DA, Karl HW, Weinberg JA, McCloskeyC. Adverse sedation events in pediatrics: a critical incidentanalysis <strong>of</strong> contributory factors. <strong>Pediatric</strong>s. 2000;105:805–81447. Kim G, Green SM, Denmark TK, Krauss B. Ventilatory responseduring dissociative sedation in children: a pilot study.Acad Emerg Med. 2003;10:140–14548. Coté CJ. Sedation <strong>for</strong> the pediatric patient: a review. PediatrClin North Am. 1994;41:31–5849. Mason KP, Burrows PE, Dorsey MM, Zurakowski D, Krauss B.Accuracy <strong>of</strong> capnography with a 30 foot nasal cannula <strong>for</strong>monitoring respiratory rate <strong>and</strong> end-tidal CO 2 in children.J Clin Monit Comput. 2000;16:259–26250. McQuillen KK, Steele DW. Capnography during sedation/analgesia in the pediatric emergency department. PediatrEmerg Care. 2000;16:401–40451. Malviya S, Voepel-Lewis T, Tait AR. Adverse events <strong>and</strong> riskfactors associated with the sedation <strong>of</strong> children by nonanesthesiologists[published correction appears in Anesth Analg.1998;86:227]. Anesth Analg. 1997;85:1207–121352. Coté CJ, Rolf N, Liu LM, et al. A single-blind study <strong>of</strong> combinedpulse oximetry <strong>and</strong> capnography in children. Anesthesiology.1991;74:980–98753. Scottish Intercollegiate <strong>Guidelines</strong> Network. Safe Sedation <strong>of</strong>Children Undergoing Diagnostic <strong>and</strong> Therapeutic Procedures: A NationalClinical Guideline. Edinburgh, Scotl<strong>and</strong>: Scottish Intercollegiate<strong>Guidelines</strong> Network; 2003. Available at: www.sign.ac.uk/pdf/sign58.pdf. Accessed February 7, 200654. H<strong>of</strong>fman GM, Nowakowski R, Troshynski TJ, Berens RJ,Weisman SJ. Risk reduction in pediatric procedural sedationby application <strong>of</strong> an American Academy <strong>of</strong> <strong>Pediatric</strong>s/American Society <strong>of</strong> Anesthesiologists process model. <strong>Pediatric</strong>s.2002;109:236–24355. Krauss B. <strong>Management</strong> <strong>of</strong> acute pain <strong>and</strong> anxiety in childrenundergoing procedures in the emergency department. PediatrEmerg Care. 2001;17:115–12256. Dial S, Silver P, Bock K, Sagy M. <strong>Pediatric</strong> sedation <strong>for</strong> procedurestitrated to a desired degree <strong>of</strong> immobility results inunpredictable depth <strong>of</strong> sedation. Pediatr Emerg Care. 2001;17:414–42057. Maxwell LG, Yaster M. The myth <strong>of</strong> conscious sedation. ArchPediatr Adolesc Med. 1996;150:665–66758. Coté CJ. “Conscious sedation”: time <strong>for</strong> this oxymoron to goaway! J Pediatr. 2001;139:15–1759. Motas D, McDermott NB, VanSickle T, Friesen RH. Depth <strong>of</strong>consciousness <strong>and</strong> deep sedation attained in children as administeredby nonanaesthesiologists in a children’s hospital.Paediatr Anaesth. 2004;14:256–26060. Nahata MC, Clotz MA, Krogg EA. Adverse effects <strong>of</strong> meperidine,promethazine, <strong>and</strong> chlorpromazine <strong>for</strong> sedation in pediatricpatients. Clin Pediatr (Phila). 1985;24:558–56061. Brown ET, Corbett SW, Green SM. Iatrogenic cardiopulmo-PEDIATRICS Volume 118, Number 6, December 2006 2597Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


nary arrest during pediatric sedation with meperidine,promethazine, <strong>and</strong> chlorpromazine. Pediatr Emerg Care. 2001;17:351–35362. Benusis KP, Kapaun D, Furnam LJ. Respiratory depression ina child following meperidine, promethazine, <strong>and</strong> chlorpromazinepremedication: report <strong>of</strong> case. ASDC J Dent Child. 1979;46:50–5363. Garriott JC, Di Maio VJ. Death in the dental chair: three drugfatalities in dental patients. J Toxicol Clin Toxicol. 1982;19:987–99564. Goodson JM, Moore PA. Life-threatening reactions after pedodonticsedation: an assessment <strong>of</strong> narcotic, local anesthetic,<strong>and</strong> antiemetic drug interaction. J Am Dent Assoc. 1983;107:239–24565. Jastak JT, Pallasch T. Death after chloral hydrate sedation:report <strong>of</strong> case. J Am Dent Assoc. 1988;116:345–34866. Jastak JT, Peskin RM. Major morbidity or mortality from<strong>of</strong>fice anesthetic procedures: a closed-claim analysis <strong>of</strong> 13cases. Anesth Prog. 1991;38:39–4467. Kaufman E, Jastak JT. Sedation <strong>for</strong> outpatient dental procedures.Compend Contin Educ Dent. 1995;16:462, 464, 466passim; quiz 48068. Wilson S. Pharmacological management <strong>of</strong> the pediatric dentalpatient. Pediatr Dent. 2004;26:131–13669. Sams DR, Thornton JB, Wright JT. The assessment <strong>of</strong> two oralsedation drug regimens in pediatric dental patients. J DentChild. 1992;59:306–31270. Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Tremper K,Naughton N. Depth <strong>of</strong> sedation in children undergoing computedtomography: validity <strong>and</strong> reliability <strong>of</strong> the University <strong>of</strong>Michigan Sedation Scale (UMSS). Br J Anaesth. 2002;88:241–24571. Newton JT, Shah S, Patel H, Sturmey P. Non-pharmacologicalapproaches to behaviour management in children. Dent Update.2003;30:194–19972. Peretz B, Bimstein E. The use <strong>of</strong> imagery suggestions duringadministration <strong>of</strong> local anesthetic in pediatric dental patients.ASDC J Dent Child. 2000;67:263–26773. Iserson KV. Hypnosis <strong>for</strong> pediatric fracture reduction. J EmergMed. 1999;17:53–5674. Rusy LM, Weisman SJ. Complementary therapies <strong>for</strong> acutepediatric pain management. Pediatr Clin North Am. 2000;47:589–59975. Langley P. Guided imagery: a review <strong>of</strong> effectiveness in thecare <strong>of</strong> children. Paediatr Nurs. 1999;11(3):18–2176. Ott MJ. Imagine the possibilities! Guided imagery with toddlers<strong>and</strong> pre-schoolers. Pediatr Nurs. 1996;22:34–3877. Singer AJ, Stark MJ. LET versus EMLA <strong>for</strong> pretreatinglacerations: a r<strong>and</strong>omized trial. Acad Emerg Med. 2001;8:223–23078. Taddio A, Gurguis MG, Koren G. Lidocaine-prilocaine creamversus tetracaine gel <strong>for</strong> procedural pain in children. AnnPharmacother. 2002;36:687–69279. Eichenfield LF, Funk A, Fallon-Friedl<strong>and</strong>er S, CunninghamBB. A clinical study to evaluate the efficacy <strong>of</strong> ELA-Max (4%liposomal lidocaine) as compared with eutectic mixture <strong>of</strong>local anesthetics cream <strong>for</strong> pain reduction <strong>of</strong> venipuncture inchildren. <strong>Pediatric</strong>s. 2002;109:1093–109980. Shaw AJ, Welbury RR. The use <strong>of</strong> hypnosis in a sedation clinic<strong>for</strong> dental extractions in children: report <strong>of</strong> 20 cases. ASDC JDent Child. 1996;63:418–42081. Aitken JC, Wilson S, Coury D, Moursi AM. The effect <strong>of</strong> musicdistraction on pain, anxiety <strong>and</strong> behavior in pediatric dentalpatients. Pediatr Dent. 2002;24:114–11882. Domino KB. Office-based anesthesia: lessons learned from theclosed claims project. ASA Newsletter. 2001;65:9–11, 1583. American Heart Association. <strong>Pediatric</strong> Advanced Life SupportProvider Manual. Dallas, TX: American Heart Association; 200284. American Academy <strong>of</strong> <strong>Pediatric</strong>s <strong>and</strong> American College <strong>of</strong>Emergency Physicians. APLS: The <strong>Pediatric</strong> Emergency MedicineResource. Rev 4th ed. Boston, MA: Jones <strong>and</strong> BartlettPublishers; 200485. Wheeler M. <strong>Management</strong> strategies <strong>for</strong> the difficult pediatricairway. In: Riazi J, ed. Anesthesiology Clinics <strong>of</strong> North America.Philadelphia, PA: WB Saunders Co; 1998:743–76186. Sullivan KJ, Kissoon N. Securing the child’s airway in theemergency department. Pediatr Emerg Care. 2002;18:108–12187. Levy RJ, Helfaer MA. <strong>Pediatric</strong> airway issues. Crit Care Clin.2000;16:489–50488. Krauss B, Green SM. Procedural sedation <strong>and</strong> analgesia inchildren. Lancet. 2006;367:766–78089. Krauss B, Green SM. Sedation <strong>and</strong> analgesia <strong>for</strong> procedures inchildren. N Engl J Med. 2000;342:938–94590. Ferrari LR. Anesthesia <strong>and</strong> Pain <strong>Management</strong> <strong>for</strong> the <strong>Pediatric</strong>ian.Baltimore, MD: John Hopkins University Press; 199991. Malviya S, Naughton NN, Tremper KT, eds. Sedation Analgesia<strong>for</strong> Diagnostic <strong>and</strong> Therapeutic Procedures. Totowa, NJ: HumanaPress; 200192. Yaster M, Krane EJ, Kaplan RF, Coté CJ, Lappe DG, eds.<strong>Pediatric</strong> Pain <strong>Management</strong> <strong>and</strong> Sedation H<strong>and</strong>book. St Louis,MO: CV Mosby; 199793. Cravero JP, Blike GT. Review <strong>of</strong> pediatric sedation. AnesthAnalg. 2004;99:1355–136494. American Society <strong>of</strong> Anesthesiologists. St<strong>and</strong>ards <strong>for</strong> Basic Intra-operative<strong>Monitoring</strong>. Chicago, IL: American Society <strong>of</strong>Anesthesiologists; 2005. Available at: www.asahq.org/publicationsAndServices/st<strong>and</strong>ards/02.pdf. Accessed October20, 200695. Mace SE, Barata IA, Cravero JP et al. Clinical policy: evidence-basedapproach to pharmacologic agents used in pediatricsedation <strong>and</strong> analgesia in the emergency department.Ann Emerg Med. 2004;44:342–37796. Deshp<strong>and</strong>e JK, Tobias JD, eds. The <strong>Pediatric</strong> Pain H<strong>and</strong>book. StLouis, MO: Mosby; 199697. Alcaino EA. Conscious sedation in paediatric dentistry: currentphilosophies <strong>and</strong> techniques. Ann R Australas Coll DentSurg. 2000;15:206–21098. Mitchell AA, Louik C, Lacouture P, Slone D, Goldman P,Shapiro S. Risks to children from computed tomographic scanpremedication. JAMA. 1982;247:2385–238899. Pershad J, Palmisano P, Nichols M. Chloral hydrate: the good<strong>and</strong> the bad. Pediatr Emerg Care. 1999;15:432–435100. Malviya S, Voepel-Lewis T, Ludomirsky A, Marshall J, TaitAR. Can we improve the assessment <strong>of</strong> discharge readiness? Acomparative study <strong>of</strong> observational <strong>and</strong> objective measures <strong>of</strong>depth <strong>of</strong> sedation in children. Anesthesiology. 2004;100:218–224101. American Academy <strong>of</strong> <strong>Pediatric</strong>s, Committee on Injury <strong>and</strong>Poison Prevention. Transporting children with special healthcare needs. <strong>Pediatric</strong>s. 1999;104:988–992102. American Academy <strong>of</strong> <strong>Pediatric</strong>s, Committee on Bioethics.In<strong>for</strong>med consent, parental permission, <strong>and</strong> assent in pediatricpractice. <strong>Pediatric</strong>s. 1995;95:314–317103. Malviya S, Voepel-Lewis T, Prochaska G, Tait AR. Prolongedrecovery <strong>and</strong> delayed side effects <strong>of</strong> sedation <strong>for</strong> diagnosticimaging studies in children. <strong>Pediatric</strong>s. 2000;105(3). Availableat: www.pediatrics.org/cgi/content/full/105/3/e42104. Babl FE, Puspitadewi A, Barnett P, Oakley E, Spicer M. Preproceduralfasting state <strong>and</strong> adverse events in children receivingnitrous oxide <strong>for</strong> procedural sedation <strong>and</strong> analgesia. PediatrEmerg Care. 2005;21:736–743105. Roback MG, Bajaj L, Wathen JE, Bothner J. Preproceduralfasting <strong>and</strong> adverse events in procedural sedation <strong>and</strong> anal-2598 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


gesia in a pediatric emergency department: are they related?Ann Emerg Med. 2004;44:454–459106. Agrawal D, Manzi SF, Gupta R, Krauss B. Preproceduralfasting state <strong>and</strong> adverse events in children undergoing proceduralsedation <strong>and</strong> analgesia in a pediatric emergency department.Ann Emerg Med. 2003;42:636–646107. Green SM. Fasting is a consideration—not a necessity—<strong>for</strong>emergency department procedural sedation <strong>and</strong> analgesia.Ann Emerg Med. 2003;42:647–650108. Green SM, Krauss B. Pulmonary aspiration risk during emergencydepartment procedural sedation: an examination <strong>of</strong> therole <strong>of</strong> fasting <strong>and</strong> sedation depth. Acad Emerg Med. 2002;9:35–42109. Treston G. Prolonged pre-procedure fasting time is unnecessarywhen using titrated intravenous ketamine <strong>for</strong> paediatricprocedural sedation. Emerg Med Australas. 2004;16:145–150110. Green SM, Krauss B. Ketamine is a safe, effective, <strong>and</strong> appropriatetechnique <strong>for</strong> emergency department paediatric proceduralsedation. Emerg Med J. 2004;21:271–272111. Gorski JC, Huang SM, Pinto A, et al. The effect <strong>of</strong> echinacea(Echinacea purpurea root) on cytochrome P450 activity in vivo.Clin Pharmacol Ther. 2004;75:89–100112. Hall SD, Wang Z, Huang SM, et al. The interaction between StJohn’s wort <strong>and</strong> an oral contraceptive. Clin Pharmacol Ther.2003;74:525–535113. Markowitz JS, Donovan JL, DeVane CL, et al. Effect <strong>of</strong> StJohn’s wort on drug metabolism by induction <strong>of</strong> cytochromeP450 3A4 enzyme. JAMA. 2003;290:1500–1504114. Spinella M. Herbal medicines <strong>and</strong> epilepsy: the potential <strong>for</strong>benefit <strong>and</strong> adverse effects. Epilepsy Behav. 2001;2:524–532115. Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, HallSD. The effects <strong>of</strong> St John’s wort (Hypericum per<strong>for</strong>atum) onhuman cytochrome P450 activity. Clin Pharmacol Ther. 2001;70:317–326116. Xie HG, Kim RB. St John’s wort-associated drug interactions:short-term inhibition <strong>and</strong> long-term induction [publishedcorrection appears in Clin Pharmacol Ther. 2005;78:550]? ClinPharmacol Ther. 2005;78:19–24117. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines <strong>and</strong> perioperativecare. JAMA. 2001;286:208–216118. Abebe W. Herbal medication: potential <strong>for</strong> adverse interactionswith analgesic drugs. J Clin Pharm Ther. 2002;27:391–401119. von Rosensteil NA, Adam D. Macrolide antibacterials: druginteractions <strong>of</strong> clinical significance. Drug Saf. 1995;13:105–122120. Hiller A, Olkkola KT, Isohanni P, Saarnivaara L. Unconsciousnessassociated with midazolam <strong>and</strong> erythromycin. Br J Anaesth.1990;65:826–828121. Mattila MJ, Idanpaan-Heikkila JJ, Tornwall M, VanakoskiJ. Oral single doses <strong>of</strong> erythromycin <strong>and</strong> roxithromycin mayincrease the effects <strong>of</strong> midazolam on human per<strong>for</strong>mance.Pharmacol Toxicol. 1993;73:180–185122. Olkkola KT, Aranko K, Luurila H, et al. A potentially hazardousinteraction between erythromycin <strong>and</strong> midazolam. ClinPharmacol Ther. 1993;53:298–305123. Flockhart DA, Oesterheld JR. Cytochrome P450-mediateddrug interactions. Child Adolesc Psychiatr Clin N Am. 2000;9:43–76124. Yuan R, Flockhart DA, Balian JD. Pharmacokinetic <strong>and</strong> pharmacodynamicconsequences <strong>of</strong> metabolism-based drug interactionswith alprazolam, midazolam, <strong>and</strong> triazolam. J ClinPharmacol. 1999;39:1109–1125125. Young B. Review: mixing new cocktails—drug interactions inantiretroviral regimens. AIDS Patient Care STDS. 2005;19:286–297126. Wilkinson GR. Drug metabolism <strong>and</strong> variability among patientsin drug response. N Engl J Med. 2005;352:2211–2221127. American Academy <strong>of</strong> <strong>Pediatric</strong>s, Section on <strong>Pediatric</strong> Pulmonology,Subcommittee on Obstructive Sleep Apnea Syndrome.Clinical practice guideline: diagnosis <strong>and</strong> management<strong>of</strong> childhood obstructive sleep apnea syndrome.<strong>Pediatric</strong>s. 2002;109:704–712128. Schechter MS. Technical report: diagnosis <strong>and</strong> management<strong>of</strong> childhood obstructive sleep apnea syndrome. <strong>Pediatric</strong>s.2002;109(4). Available at: www.pediatrics.org/cgi/content/full/109/4/e69129. Litman RS, Kottra JA, Berkowitz RJ, Ward DS. Upper airwayobstruction during midazolam/nitrous oxide sedation in childrenwith enlarged tonsils. Pediatr Dent. 1998;20:318–320130. Fishbaugh DF, Wilson S, Preisch JW, Weaver JM II. Relationship<strong>of</strong> tonsil size on an airway blockage maneuver in childrenduring sedation. Pediatr Dent. 1997;19:277–281131. Mayers DJ, Hindmarsh KW, Sankaran K, Gorecki DK, KasianGF. Chloral hydrate disposition following single-dose administrationto critically ill neonates <strong>and</strong> children. Dev PharmacolTher. 1991;16:71–77132. Terndrup TE, Dire DJ, Madden CM, Davis H, Cantor RM,Gavula DP. A prospective analysis <strong>of</strong> intramuscular meperidine,promethazine, <strong>and</strong> chlorpromazine in pediatric emergencydepartment patients. Ann Emerg Med. 1991;20:31–35133. Coté CJ. Discharge criteria <strong>for</strong> children sedated bynonanesthesiologists: is “safe” really safe enough? Anesthesiology.2004;100:207–209134. Macnab AJ, Levine M, Glick N, Susak L, Baker-Brown G. Aresearch tool <strong>for</strong> measurement <strong>of</strong> recovery from sedation: theVancouver Sedative Recovery Scale. J Pediatr Surg. 1991;26:1263–1267135. Chernik DA, Gillings D, Laine H, et al. Validity <strong>and</strong> reliability<strong>of</strong> the Observer’s Assessment <strong>of</strong> Alertness/Sedation Scale:study with intravenous midazolam. J Clin Psychopharmacol.1990;10:244–251136. Bagian JP, Lee C, Gosbee J, et al. Developing <strong>and</strong> deploying apatient safety program in a large health care delivery system:you can’t fix what you don’t know about. Jt Comm J QualImprov. 2001;27:522–532137. May T, Aulisio MP. Medical malpractice, mistake prevention,<strong>and</strong> compensation. Kennedy Inst Ethics J. 2001;11:135–146138. Kaz<strong>and</strong>jian VA. When you hear ho<strong>of</strong>s, think horses, notzebras: an evidence-based model <strong>of</strong> health care accountability.J Eval Clin Pract. 2002;8:205–213139. Connor M, Ponte PR, Conway J. Multidisciplinary approachesto reducing error <strong>and</strong> risk in a patient care setting. Crit CareNurs Clin North Am. 2002;14:359–367140. Gosbee J. Human factors engineering <strong>and</strong> patient safety. QualSaf Health Care. 2002;11:352–354141. Barker SJ, Hyatt J, Shah NK, Kao YJ. The effect <strong>of</strong> sensormalpositioning on pulse oximeter accuracy during hypoxemia.Anesthesiology. 1993;79:248–254142. Kelleher JF, Ruff RH. The penumbra effect: vasomotiondependentpulse oximeter artifact due to probe malposition.Anesthesiology. 1989;71:787–791143. Hart LS, Berns SD, Houck CS, Boenning DA. The value <strong>of</strong>end-tidal CO 2 monitoring when comparing three methods <strong>of</strong>conscious sedation <strong>for</strong> children undergoing painful proceduresin the emergency department. Pediatr Emerg Care. 1997;13:189–193144. Aubuchon RW. Sedation liabilities in pedodontics [abstract].Pediatr Dent. 1982;4:171–180145. Fitzmaurice LS, Wasserman GS, Knapp JF, Roberts DK, WaeckerleJF, Fox M. TAC use <strong>and</strong> absorption <strong>of</strong> cocaine in apediatric emergency department. Ann Emerg Med. 1990;19:515–518PEDIATRICS Volume 118, Number 6, December 2006 2599Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


146. Tipton GA, DeWitt GW, Eisenstein SJ. Topical TAC (tetracaine,adrenaline, cocaine) solution <strong>for</strong> local anesthesia inchildren: prescribing inconsistency <strong>and</strong> acute toxicity. SouthMed J. 1989;82:1344–1346147. Gunter JB. Benefit <strong>and</strong> risks <strong>of</strong> local anesthetics in infants <strong>and</strong>children. Paediatr Drugs. 2002;4:649–672148. Resar LM, Helfaer MA. Recurrent seizures in a neonate afterlidocaine administration. J Perinatol. 1998;18:193–195149. Yagiela JA. Local anesthetics. In: Yagiela JA, Dowd FJ, NeidleEA, eds. Pharmacology <strong>and</strong> Therapeutics <strong>for</strong> Dentistry. St Louis,MO: Mosby; 2004:251–270150. Haas DA. An update on local anesthetics in dentistry. J CanDent Assoc. 2002;68:546–551151. Malamed SF. Local anesthetic considerations in dental specialties.In: Malamed SF, ed. H<strong>and</strong>book <strong>of</strong> Local Anesthesia. 5thed. St Louis, MO: Mosby; 2004:269, 274–275152. Malamed SF. The needle. In: Malamed SF, ed. H<strong>and</strong>book <strong>of</strong>Local Anesthesia. 5th ed. St Louis, MO: Mosby; 2004:99–107153. Malamed SF. Clinical action <strong>of</strong> specific agents. In: MalamedSF, ed. H<strong>and</strong>book <strong>of</strong> Local Anesthesia. 5th ed. St Louis, MO:Mosby; 2004:55–81154. Ram D, Amir E. Comparison <strong>of</strong> articaine 4% <strong>and</strong> lidocaine2% in paediatric dental patients. Int J Paediatr Dent. 2006;16:252–256155. Jakobs W, Ladwig B, Cichon P, Ortel R, Kirch W. Serum levels<strong>of</strong> articaine 2% <strong>and</strong> 4% in children. Anesth Prog. 1995;42:113–115156. Wright GZ, Weinberger SJ, Friedman CS, Plotzke OB. Use <strong>of</strong>articaine local anesthesia in children under 4 years <strong>of</strong> age: aretrospective report. Anesth Prog. 1989;36:268–271157. Malamed SF, Gagnon S, Leblanc D. A comparison betweenarticaine HCl <strong>and</strong> lidocaine HCl in pediatric dental patients.Pediatr Dent. 2000;22:307–311158. American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry. Guideline on appropriateuse <strong>of</strong> local anesthesia <strong>for</strong> pediatric dental patients.Available at: www.aapd.org/media/Policies<strong>Guidelines</strong>/GLocalAnesthesia.pdf. Accessed September 14, 2006159. Next-generation pulse oximetry. Health Devices. 2003;32:49–103160. Barker SJ. “Motion-resistant” pulse oximetry: a comparison<strong>of</strong> new <strong>and</strong> old models. Anesth Analg. 2002;95:967–972161. Malviya S, Reynolds PI, Voepel-Lewis T, et al. False alarms<strong>and</strong> sensitivity <strong>of</strong> conventional pulse oximetry versus theMasimo SET technology in the pediatric postanesthesia careunit. Anesth Analg. 2000;90:1336–1340162. Barker SJ, Shah NK. Effects <strong>of</strong> motion on the per<strong>for</strong>mance <strong>of</strong>pulse oximeters in volunteers. Anesthesiology. 1996;85:774–781163. Barker SJ, Shah NK. The effects <strong>of</strong> motion on the per<strong>for</strong>mance<strong>of</strong> pulse oximeters in volunteers (revised publication).Anesthesiology. 1997;86:101–108164. Colman Y, Krauss B. Microstream capnography technology: anew approach to an old problem. J Clin Monit Comput. 1999;15:403–409165. Wright SW. Conscious sedation in the emergency department:the value <strong>of</strong> capnography <strong>and</strong> pulse oximetry. Ann Emerg Med.1992;21:551–555166. Croswell RJ, Dilley DC, Lucas WJ, Vann WF Jr. A comparison<strong>of</strong> conventional versus electronic monitoring <strong>of</strong> sedated pediatricdental patients. Pediatr Dent. 1995;17:332–339167. Tobias JD. End-tidal carbon dioxide monitoring during sedationwith a combination <strong>of</strong> midazolam <strong>and</strong> ketamine <strong>for</strong>children undergoing painful, invasive procedures. PediatrEmerg Care. 1999;15:173–175168. Primosch RE, Buzzi IM, Jerrell G. <strong>Monitoring</strong> pediatric dentalpatients with nasal mask capnography. Pediatr Dent. 2000;22:120–124169. Roel<strong>of</strong>se J. Conscious sedation: making our treatment optionssafe <strong>and</strong> sound. SADJ. 2000;55:273–276170. Wilson S, Creedon RL, George M, Troutman K. A history <strong>of</strong>sedation guidelines: where we are headed in the future. PediatrDent. 1996;18:194–199171. Miner JR, Heegaard W, Plummer D. End-tidal carbon dioxidemonitoring during procedural sedation. Acad Emerg Med.2002;9:275–280172. Vascello LA, Bowe EA. A case <strong>for</strong> capnographic monitoring asa st<strong>and</strong>ard <strong>of</strong> care. J Oral Maxill<strong>of</strong>ac Surg. 1999;57:1342–1347173. Iwasaki J, Vann WF Jr, Dilley DC, Anderson JA. An investigation<strong>of</strong> capnography <strong>and</strong> pulse oximetry as monitors <strong>of</strong>pediatric patients sedated <strong>for</strong> dental treatment. Pediatr Dent.1989;11:111–117174. Berry AM, Brimacombe JR, Verghese C. The laryngeal maskairway in emergency medicine, neonatal resuscitation, <strong>and</strong>intensive care medicine. Int Anesthesiol Clin. 1998;36:91–109175. Patterson MD. Resuscitation update <strong>for</strong> the pediatrician. PediatrClin North Am. 1999;46:1285–1303176. Selim M, Mowafi H, Al Ghamdi A, Adu-Gyamfi Y. Intubationvia LMA in pediatric patients with difficult airways. Can JAnaesth. 1999;46:891–893177. Munro HM, Butler PJ, Washington EJ. Freeman-Sheldon(whistling face) syndrome: anaesthetic <strong>and</strong> airway management.Paediatr Anaesth. 1997;7:345–348178. Rowe R, Cohen RA. An evaluation <strong>of</strong> a virtual reality airwaysimulator. Anesth Analg. 2002;95:62–66179. Medina LS, Racadio JM, Schwid HA. Computers in radiology.The sedation, analgesia, <strong>and</strong> contrast media computerizedsimulator: a new approach to train <strong>and</strong> evaluate radiologists’responses to critical incidents. Pediatr Radiol. 2000;30:299–305180. Blike G, Cravero J, Nelson E. Same patients, same criticalevents—different systems <strong>of</strong> care, different outcomes: description<strong>of</strong> a human factors approach aimed at improving theefficacy <strong>and</strong> safety <strong>of</strong> sedation/analgesia care. Qual ManagHealth Care. 2001;10:17–36181. Kanal E, Shellock FG, Talagala L. Safety considerations in MRimaging. Radiology. 1990;176:593–606182. Shellock FG, Kanal E. Burns associated with the use <strong>of</strong> monitoringequipment during MR procedures. J Magn Reson Imaging.1996;6:271–272183. Shellock FG. Magnetic resonance safety update 2002: implants<strong>and</strong> devices. J Magn Reson Imaging. 2002;16:485–496184. Dempsey MF, Condon B, Hadley DM. MRI safety review.Semin Ultrasound CT MR. 2002;23:392–401185. National Institute <strong>for</strong> Occupational Safety <strong>and</strong> Health. Criteria<strong>for</strong> a recommended st<strong>and</strong>ard: occupational exposure to wasteanesthetic gases <strong>and</strong> vapors. Publication 77–140. 1977. Availableat: www.cdc.gov/niosh/77–140.html. Accessed October4, 2006186. O’Sullivan I, Benger J. Nitrous oxide in emergency medicine.Emerg Med J. 2003;20:214–217187. Kennedy RM, Luhmann JD, Luhmann SJ. Emergency departmentmanagement <strong>of</strong> pain <strong>and</strong> anxiety related to orthopedicfracture care: a guide to analgesic techniques <strong>and</strong> proceduralsedation in children. Paediatr Drugs. 2004;6:11–31188. Frampton A, Browne GJ, Lam LT, Cooper MG, Lane LG.Nurse administered relative analgesia using high concentrationnitrous oxide to facilitate minor procedures in children inan emergency department. Emerg Med J. 2003;20:410–413189. Everitt I, Younge P, Barnett P. Paediatric sedation in emergencydepartment: what is our practice? Emerg Med(Fremantle). 2002;14:62–66190. Krauss B. Continuous-flow nitrous oxide: searching <strong>for</strong> theideal procedural anxiolytic <strong>for</strong> toddlers. Ann Emerg Med. 2001;37:61–622600 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


191. Otley CC, Nguyen TH. Conscious sedation <strong>of</strong> pediatric patientswith combination oral benzodiazepines <strong>and</strong> inhalednitrous oxide. Dermatol Surg. 2000;26:1041–1044192. Luhmann JD, Kennedy RM, Jaffe DM, McAllister JD. Continuous-flowdelivery <strong>of</strong> nitrous oxide <strong>and</strong> oxygen: a safe <strong>and</strong>cost-effective technique <strong>for</strong> inhalation analgesia <strong>and</strong> sedation<strong>of</strong> pediatric patients. Pediatr Emerg Care. 1999;15:388–392193. Burton JH, Auble TE, Fuchs SM. Effectiveness <strong>of</strong> 50% nitrousoxide/50% oxygen during laceration repair in children. AcadEmerg Med. 1998;5:112–117194. Gregory PR, Sullivan JA. Nitrous oxide compared with intravenousregional anesthesia in pediatric <strong>for</strong>earm fracture manipulation.J Pediatr Orthop. 1996;16:187–191195. Hennrikus WL, Shin AY, Klingelberger CE. Self-administerednitrous oxide <strong>and</strong> a hematoma block <strong>for</strong> analgesia in theoutpatient reduction <strong>of</strong> fractures in children. J Bone Joint SurgAm. 1995;77:335–339196. Hennrikus WL, Simpson RB, Klingelberger CE, Reis MT. Selfadministerednitrous oxide analgesia <strong>for</strong> pediatric fracturereductions. J Pediatr Orthop. 1994;14:538–542197. Wattenmaker I, Kasser JR, McGravey A. Self-administerednitrous oxide <strong>for</strong> fracture reduction in children in an emergencyroom setting. J Orthop Trauma. 1990;4:35–38198. Gamis AS, Knapp JF, Glenski JA. Nitrous oxide analgesia in apediatric emergency department. Ann Emerg Med. 1989;18:177–181199. Kalach N, Barbier C, el Kohen R, et al. Tolerance <strong>of</strong> nitrousoxide-oxygen sedation <strong>for</strong> painful procedures in emergencypediatrics: report <strong>of</strong> 600 cases [in French]. Arch Pediatr. 2002;9:1213–1215200. Michaud L, Gottr<strong>and</strong> F, Ganga-Z<strong>and</strong>zou PS, et al. Nitrousoxide sedation in pediatric patients undergoing gastrointestinalendoscopy. J Pediatr Gastroenterol Nutr. 1999;28:310–314201. Baskett PJ. Analgesia <strong>for</strong> the dressing <strong>of</strong> burns in children: amethod using neuroleptanalgesia <strong>and</strong> Entonox. Postgrad MedJ. 1972;48:138–142202. Veerkamp JS, van Amerongen WE, Hoogstraten J, Groen HJ.Dental treatment <strong>of</strong> fearful children, using nitrous oxide. Part1: treatment times. ASDC J Dent Child. 1991;58:453–457203. Veerkamp JS, Gruythuysen RJ, van Amerongen WE, HoogstratenJ. Dental treatment <strong>of</strong> fearful children using nitrousoxide. Part 2: the parent’s point <strong>of</strong> view. ASDC J Dent Child.1992;59:115–119204. Veerkamp JS, Gruythuysen RJ, van Amerongen WE, HoogstratenJ. Dental treatment <strong>of</strong> fearful children using nitrousoxide. Part 3: anxiety during sequential visits. ASDC J DentChild. 1993;60:175–182205. Veerkamp JS, Gruythuysen RJ, Hoogstraten J, van AmerongenWE. Dental treatment <strong>of</strong> fearful children using nitrousoxide. Part 4: anxiety after two years. ASDC J Dent Child.1993;60:372–376206. Houpt MI, Limb R, Livingston RL. Clinical effects <strong>of</strong> nitrousoxide conscious sedation in children. Pediatr Dent. 2004;26:29–36207. Shapira J, Holan G, Guelmann M, Cahan S. Evaluation <strong>of</strong> theeffect <strong>of</strong> nitrous oxide <strong>and</strong> hydroxyzine in controlling thebehavior <strong>of</strong> the pediatric dental patient. Pediatr Dent. 1992;14:167–170208. Primosch RE, Buzzi IM, Jerrell G. Effect <strong>of</strong> nitrous oxideoxygeninhalation with scavenging on behavioral <strong>and</strong> physiologicalparameters during routine pediatric dental treatment.Pediatr Dent. 1999;21:417–420209. McCann W, Wilson S, Larsen P, Stehle B. The effects <strong>of</strong>nitrous oxide on behavior <strong>and</strong> physiological parameters duringconscious sedation with a moderate dose <strong>of</strong> chloral hydrate<strong>and</strong> hydroxyzine. Pediatr Dent. 1996;18:35–41210. Wilson S, Matusak A, Casamassimo PS, Larsen P. The effects<strong>of</strong> nitrous oxide on pediatric dental patients sedated withchloral hydrate <strong>and</strong> hydroxyzine. Pediatr Dent. 1998;20:253–258211. Litman RS, Kottra JA, Berkowitz RJ, Ward DS. Breathingpatterns <strong>and</strong> levels <strong>of</strong> consciousness in children during administration<strong>of</strong> nitrous oxide after oral midazolam premedication.J Oral Maxill<strong>of</strong>ac Surg. 1997;55:1372–1377212. Litman RS, Kottra JA, Verga KA, Berkowitz RJ, Ward DS.Chloral hydrate sedation: the additive sedative <strong>and</strong> respiratorydepressant effects <strong>of</strong> nitrous oxide. Anesth Analg. 1998;86:724–728213. American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry. Guideline on appropriateuse <strong>of</strong> nitrous oxide <strong>for</strong> pediatric dental patients. Availableat: www.aapd.org/media/Policies<strong>Guidelines</strong>/GNitrous.pdf. AccessedSeptember 14, 2006PEDIATRICS Volume 118, Number 6, December 2006 2601Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


APPENDIX 1Class IClass IIClass IIIClass IVClass VASA Physical Status ClassificationA normally healthy patientA patient with mild systemic disease (eg, controlled reactiveairway disease)A patient with severe systemic disease (eg, a child who isactively wheezing)A patient with severe systemic disease that is a constantthreat to life (eg, a child with status asthmaticus)A moribund patient who is not expected to survive withoutthe operation (eg, a patient with severe cardiomyopathyrequiring heart transplantation)APPENDIX 2 Recommended Discharge Criteria1. Cardiovascular function <strong>and</strong> airway patency are satisfactory <strong>and</strong> stable.2. The patient is easily arousable, <strong>and</strong> protective reflexes are intact.3. The patient can talk (if age appropriate).4. The patient can sit up unaided (if age appropriate).5. For a very young or h<strong>and</strong>icapped child incapable <strong>of</strong> the usually expectedresponses, the presedation level <strong>of</strong> responsiveness or a level as close aspossible to the normal level <strong>for</strong> that child should be achieved.6. The state <strong>of</strong> hydration is adequate.APPENDIX 3 Drugs That May Be Needed to Rescue a SedatedPatientAlbuterol <strong>for</strong> inhalationAmmonia spiritsAtropineDiphenhydramineDiazepamEpinephrine (1:1000, 1:10 000)FlumazenilGlucose (25% or 50%)Lidocaine (cardiac lidocaine, local infiltration)LorazepamMethylprednisoloneNaloxoneOxygenFosphenytoinRacemic epinephrineRocuroniumSodium bicarbonateSuccinylcholineThe choice <strong>of</strong> emergency drugs may vary according to individual or procedural needs.Source: American Society <strong>of</strong> Anesthesiologists, Task Force on Sedation <strong>and</strong> Analgesia by Nonanesthesiologists.Anesthesiology. 2002;96:1004–1017APPENDIX 4 Emergency Equipment That May Be Needed to Rescuea Sedated PatientIntravenous equipmentAssorted intravenous catheters (eg, 24-, 22-, 20-, 18-, <strong>and</strong> 16-gauge)TourniquetsAlcohol wipesAdhesive tapeAssorted syringes (eg, 1, 3, 5, <strong>and</strong> 10 mL)Intravenous tubing<strong>Pediatric</strong> drip (60 drops per mL)<strong>Pediatric</strong> buretteAdult drip (10 drops per mL)Extension tubing3-way stopcocksIntravenous fluidLactated Ringer solutionNormal saline solutionD 5 0.25 normal saline solution<strong>Pediatric</strong> intravenous boardsAssorted intravenous needles (eg, 25-, 22-, 20-, <strong>and</strong> 18-gauge)Intraosseous bone marrow needleSterile gauze padsAirway <strong>Management</strong> EquipmentFace masksInfant, child, small adult, medium adult, large adultBreathing bag <strong>and</strong> valve setOropharyngeal airwaysInfant, child, small adult, medium adult, large adultNasopharyngeal airwaysSmall, medium, largeLMAs (1, 1.5, 2, 2.5, 3, 4, <strong>and</strong> 5)Laryngoscope h<strong>and</strong>les (with extra batteries)Laryngoscope blades (with extra light bulbs)Straight (Miller) No. 1, 2, <strong>and</strong> 3Curved (Macintosh) No. 2 <strong>and</strong> 3Endotracheal tubes2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, <strong>and</strong> 6.0 uncuffed <strong>and</strong> 6.0, 7.0, <strong>and</strong> 8.0 cuffedStylettes (appropriate sizes <strong>for</strong> endotracheal tubes)Surgical lubricantSuction catheters (appropriate sizes <strong>for</strong> endotracheal tubes)Yankauer-type suctionNasogastric tubesNebulizer with medication kitsGloves (sterile <strong>and</strong> nonsterile, latex-free)The choice <strong>of</strong> emergency equipment may vary according to individual or procedural needs. Thepractitioner is referred to the SOAPME acronym described in the text in preparation <strong>for</strong> sedatinga child <strong>for</strong> a procedure.2602 AMERICAN ACADEMY OF PEDIATRICSDownloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012


<strong>Guidelines</strong> <strong>for</strong> <strong>Monitoring</strong> <strong>and</strong> <strong>Management</strong> <strong>of</strong> <strong>Pediatric</strong> <strong>Patients</strong> During <strong>and</strong>After Sedation <strong>for</strong> Diagnostic <strong>and</strong> Therapeutic Procedures: An UpdateAmerican Academy <strong>of</strong> <strong>Pediatric</strong>s, American Academy <strong>of</strong> <strong>Pediatric</strong> Dentistry, CharlesJ. Coté <strong>and</strong> Stephen Wilson<strong>Pediatric</strong>s 2006;118;2587DOI: 10.1542/peds.2006-2780Updated In<strong>for</strong>mation &Servicesincluding high resolution figures, can be found at:http://pediatrics.aappublications.org/content/118/6/2587.full.htmlReferencesCitationsPost-PublicationPeer Reviews (P 3 Rs)Subspecialty CollectionsPermissions & LicensingReprintsThis article cites 192 articles, 37 <strong>of</strong> which can be accessedfree at:http://pediatrics.aappublications.org/content/118/6/2587.full.html#ref-list-1This article has been cited by 30 HighWire-hosted articles:http://pediatrics.aappublications.org/content/118/6/2587.full.html#related-urlsOne P 3 R has been posted to this article:http://pediatrics.aappublications.org/cgi/eletters/118/6/2587This article, along with others on similar topics, appears inthe following collection(s):Committee on Drugshttp://pediatrics.aappublications.org/cgi/collection/committee_on_drugsTherapeutics & Toxicologyhttp://pediatrics.aappublications.org/cgi/collection/therapeutics_<strong>and</strong>_toxicologyIn<strong>for</strong>mation about reproducing this article in parts (figures,tables) or in its entirety can be found online at:http://pediatrics.aappublications.org/site/misc/Permissions.xhtmlIn<strong>for</strong>mation about ordering reprints can be found online:http://pediatrics.aappublications.org/site/misc/reprints.xhtmlPEDIATRICS is the <strong>of</strong>ficial journal <strong>of</strong> the American Academy <strong>of</strong> <strong>Pediatric</strong>s. A monthlypublication, it has been published continuously since 1948. PEDIATRICS is owned, published,<strong>and</strong> trademarked by the American Academy <strong>of</strong> <strong>Pediatric</strong>s, 141 Northwest Point Boulevard, ElkGrove Village, Illinois, 60007. Copyright © 2006 by the American Academy <strong>of</strong> <strong>Pediatric</strong>s. Allrights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Downloaded from pediatrics.aappublications.org at Medical Library on October 2, 2012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!